Final Results

Supreme PLC

05 July 2023

5 July 2023

Supreme plc

("Supreme," the "Company" or the "Group")

Audited Final Results for the Year Ended 31 March 2023

- Robust trading across FY23 and a particularly strong second half, underpinned by an outstanding performance from the Vaping category and earnings-enhancing acquisitions

- Record levels of cash generated from operations

- Very positive outlook, supported by a significant profit upgrade for FY24

Supreme (AIM:SUP), a leading manufacturer, supplier and brand owner of fast-moving consumer products, announces its audited final results for the year ended 31 March 2023 ("FY23").

Financial highlights

· Revenue growth of 19%; half of which was driven by earnings-enhancing acquisitions and the remainder from strong organic growth

· Vaping division delivered a record performance nearly doubling revenues to £76.1 million (FY22: £43.6 million) and increasing gross profit to £28.1 million (FY22: £19.5 million)

· Highly cash-generative in the period, delivering £19.3 million cash from operations in the period (FY22: £11.8 million), resulting in an Adjusted net cash⁴ position of £3.2 million by year end (FY22: Adjusted net debt⁴ of £1.9 million).

· Record levels of investment in M&A and capex ("investing activities") of £11.3 million (FY22: £3.8 million) to support future growth

· Disposal of the T-Juice brand generated £4.0 million of cash in FY23 and the ongoing strategic partnership with the buyer means Supreme retains exclusive manufacturing rights

Operational highlights

· Three acquisitions completed, with two having been successfully integrated and immediately Adjusted EBITDA¹ enhancing during the year and the third acquisition completed immediately prior to year-end

· Secured a 15-year lease on a new facility in Manchester which will significantly expand the Group's in-house distribution capabilities, with activities from the site expected in Q2 of FY24

· Significant progress reported on the Group's ESG strategy, with a particular focus on energy consumption and its people agenda

Dividends

· A final dividend, subject to shareholder approval at the Annual General Meeting on the 26 September 2023, of 2.2 pence per share.

· The Group paid an interim dividend of 0.8 pence per share, which together with the final dividend take total dividends for the year to 3.0 pence per share

Outlook / Current Trading

· The Group has made a very solid start to FY24. The core business and the FY23 acquisitions are all performing strongly and as a result the Board expects Adjusted EBITDA¹ to be ahead of latest expectations by at least £1 million.

· In addition, the Group now expects to generate a further £25-30 million of revenue and around £2 million incremental Adjusted EBITDA¹ in FY24 in respect of a master distributor appointment with the UK's leading vaping brands; Elfbar and Lost Mary.

· As a result, the Board now anticipates that trading in FY24 will be significantly ahead of current consensus⁵

Sandy Chadha, Chief Executive Officer of Supreme, commented:

"Supreme has delivered a strong performance across the year punctuated by an outstanding contribution from our Vaping division, which has almost doubled revenues in the year.

Our commitment to providing highly affordable but competitively priced products sits at the heart of our business and our diverse client base continues to provide a stable platform for growth.

As we look to the future, we remain committed to expanding our product set, both organically and via acquisition, which in turn creates greater opportunities to cross sell and forge ever closer bonds with our customers.

I am delighted with the strong performance of the Group so far in FY24 and to have had our vaping distribution capabilities recognised by one of the world's biggest vaping brands is testament to our expertise and our reputation.

Lastly, I would like to thank everyone in the business who have been exceptional throughout the year and look forward to updating all our stakeholders later in the year on our continued progress."

Retail Investor Presentation:

A presentation for retail investors covering the results for the year ended 31 March 2023 will be held at 11.00 a.m. on Thursday 6^th July 2023.

The online presentation is open to all existing and potential shareholders and registration is free. Questions can be submitted during the presentation and will be addressed at the end.

To register for the event, please go to https://www.equitydevelopment.co.uk/news-and-events/supreme-investor-presentation-6july2023

¹Adjusted EBITDA means operating profit before depreciation, amortisation and Adjusted items (as defined in Note 7 of the financial statements). Adjusted items include share-based payments charge, fair value movements on non-hedge accounted derivatives and non-recurring items

²Adjusted profit before tax means profit before tax and Adjusted items (as defined in Note 7 of the financial statements). Adjusted items include share-based payments charge, fair value movements on non-hedge accounted derivatives and non-recurring items

³Adjusted EPS means Earning per share, where Earnings are defined as profit after tax but before amortisation of acquired intangibles and Adjusted items (as defined in Note 7 of the financial statements). Adjusted items include share-based payments, fair value movements on non-hedge accounted derivatives and non-recurring items

⁴Adjusted net debt means net debt as defined in Note 29 to these financial statements excluding the impact of IFRS16

⁵Company compiled analyst consensus for the year ending 31 March 2024 prior to the release of this announcement and the vaping distribution opportunity announcement (dated 5 July 2023) was revenue of £159 million and Adjusted EBITDA¹ of £22.6 million.

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 which is part of UK law by virtue of the European Union (withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

Enquiries:

Supreme plc Sandy Chadha, Chief Executive Officer Suzanne Smith, Chief Finance Officer	via Vigo Consulting
Grant Thornton UK LLP (Nominated Adviser) Samantha Harrison / Harrison Clarke / Samuel Littler	+44 (0)20 7383 5100
Berenberg (Broker) Mark Whitmore / Marie Moy / Mara Grasso	+44 (0)20 3207 7800
Vigo Consulting (Financial Public Relations) Jeremy Garcia / Kendall Hill supreme@vigoconsulting.com	+44 (0)20 7390 0230

About Supreme

Supreme supplies products across five key categories; batteries, lighting, vaping, sports nutrition & wellness, and branded household consumer goods. The Company's capabilities span from product development and manufacturing through to its extensive retail distribution network and direct to consumer capabilities. This vertically integrated platform provides an excellent route to market for well-known brands and products.

The Group has over 3,300 active business accounts with retail customers who manage over 10,000 branded retail outlets. Customers include B&M, Home Bargains, Poundland, The Range, Sainsburys, Sports Direct, Londis, SPAR, Costcutter, Asda, Halfords, Iceland and HM Prison & Probation Service.

In addition to distributing globally-recognised brands such as Duracell, Energizer and Panasonic, and supplying lighting products exclusively under the Energizer, Eveready and JCB licenses across 45 countries, Supreme has also developed brands in-house, most notably 88Vape and has a growing footprint in Sports Nutrition & Wellness.

https://investors.supreme.co.uk/

Chair Statement

I am pleased to report that Supreme delivered a robust performance across the financial year ended 31 March 2023 with strong second half momentum going into FY24. This performance, achieved against a challenging macroeconomic backdrop, includes outstanding organic and acquisitive growth in our key Vaping division, and solid progress across our Batteries and Sports Nutrition & Wellness segments. Despite well-documented global supply chain and inflationary pressures, Supreme has continued to make significant operational and financial progress and is positioned strongly for future growth as we focus on delivering on our strategic aspirations.

Supreme delivered revenue of £155.6 million (FY22: £130.8 million), up 19% year-on-year, whilst Adjusted EBITDA¹ fell by 8% to £19.4 million (FY22: £21.1 million), a direct result of the temporary setback to Lighting. Supreme remains a highly cash-generative business, having generated cash from operations of £19.3 million (FY22: £11.8 million) and is further supported by a healthy balance sheet and unutilised borrowing facilities of £30 million. The Group's vertically integrated model remains resilient and continues to facilitate the development of the business and our various interconnected functions.

In line with our strategy to expand our in-house manufacturing and distribution operations, we secured a 15-year lease on a new facility near our existing warehouse in Manchester and remain on track to commence activities from this site in FY24.

The Vaping division remains the Group's key growth driver, and we continued our impressive trading momentum in this category throughout the financial year by delivering a 75% increase in revenue year-on-year. In addition to generating significant organic growth, largely through robust sales and complementary new product development in our market-leading 88vape brand, we delivered the immediately earnings-enhancing acquisitions of Liberty Flights, Cuts Ice and Superdragon. Liberty Flights and Cuts Ice were integrated into the wider Group, significantly scaling Supreme's vaping offering whilst providing considerable cross-sell opportunities. These acquisitions reflect the Company's strategy to support a tobacco-free UK by offering both credible and safer alternatives for nicotine consumption.

Acquired as part of the Cuts Ice transaction, we announced the disposal of the intellectual property of T-Juice to an associated company of leading French e-cigarette and e-liquids wholesale La Vape Professional Distribution ('LVP') in March 2023. This new arrangement ensures Supreme retains the exclusive manufacturing rights to T-Juice for five years, enabling the Group to focus on its core manufacturing expertise and the transaction generated £4 million of cash for the Group on completion.

Our Sports Nutrition & Wellness segment delivered a credible performance, as we continued to mitigate the effects of well-publicised inflationary raw material pressures and supply chain headwinds on the sector. Following the successful rebrand of Sci-MX in the first half of the financial year, we are well-poised to capitalise on the fast-growing global demand for sports nutrition products, including portable protein snacks and supplements, as whey prices begin to normalise.

Stabilising the Lighting division was a key priority for the Group after a temporary setback derived from customer over-stocking in FY22, and pleasingly we continued to make progress recovering the category despite its overall disappointing performance in the financial year where gross profit fell from £9.0 million in FY22 to £4.1 million in FY23. Strengthened by long-term exclusive license and distribution agreements, as well as increased networking and market expansion opportunities generated following the integration of Vendek, we continued to focus on enhancing our manufacturing of private and white label lighting products, ensuring we strive to provide the best service for brands and retailers.

As Chair I am particularly proud of the brands we have acquired this year; our extremely talented team continues to identify, execute and integrate complementary, well-priced, immediately earnings-enhancing brands into the Supreme platform, ensuring this does not detract or dilute our core business offering. It is a clear marker of the exceptional talent we have in our business. We remain focused on exploring further M&A and partnership opportunities to extend our manufacturing and distribution capabilities, retaining a diverse offering of great value, high-quality products to our customers and ultimately the consumer. We firmly believe that Supreme will continue to play an integral role in minimising the economic impact of the cost-of-living crisis on consumers, and we look ahead with confidence as we strive to deliver affordable items to market via leading retailers and our D2C online channels.

Supreme responded quickly to the cost-of-living issues faced by our colleagues and awarded an immediate 10% pay increase to more than half of our colleagues, regardless of location, role or length of service in September 2022. The scheme was directed towards those colleagues who were particularly impacted by the cost-of-living crisis. It is testament to the culture and values within our business that Sandy, our founder and CEO, volunteered to sacrifice his entire salary from then until the end of the financial year in order to finance this in FY23. We realise that our colleagues are one of our key assets, many of whom worked tirelessly through the Covid-19 pandemic and who continue to be pivotal to the future success of the Group.

Encouraged by the recent strong second half trading performance, the Board is pleased with the Group's progress, and on its behalf, I would like to thank all employees for their continued diligence and support. By responding effectively and prudently to turbulent macroeconomic trading conditions, our highly experienced management team continues to drive Supreme forward, and the Board has full confidence in the Company's ability to deliver on our medium to long term growth potential.

Paul McDonald

Non-executive Chair

4 July 2023

CEO's Review

Introduction

I am delighted to announce our results for the year ended 31 March 2023, following a period of substantial financial and operational growth for Supreme, driven by an outstanding performance from our Vaping category.

Supreme delivered an 19% increase in revenue to £155.6 million (FY22: 130.8 million), alongside a 6% growth in gross profit to £40.9 million (FY22: £38.5 million). Adjusted EBITDA¹ was £19.4 million (FY22: £21.1 million), which despite the impact of destocking within our Lighting category, proved to be a highly credible performance. The business generated cash of £19.3 million from operations in FY23 (FY22: £11.8 million) and I am particularly proud that the Group reported a positive £3.2 million cash position net of bank borrowings at year end; a £16.1 million increase versus the half year position six months earlier. Due to the highly cash-generative nature of its core operations, the Group was able to invest record levels into M&A and capital expenditure totalling £11.3 million (FY22: £3.8 million) and paid dividends of £5.4 million (FY22: £2.5 million).

We gained significant trading momentum in the second half of the year, driven by strong organic growth across our key categories. Our 88vape brand generated excellent sales traction to consolidate our position as a market leader in the vaping sector, alongside additional market traction generated by the acquisitions of Liberty Flights and Cuts Ice.

We cemented our approach to M&A during FY23 having acquired three more complementary, earnings-enhancing businesses in the vaping sector. Each acquisition brought its own well-recognised brands together with opportunities for synergies when integrated into the Supreme platform. Liberty Flights and Cuts Ice were acquired in the first half of the year and together contributed to £12.8 million of the Group's revenue growth and Superdragon was acquired immediately before year end and has already made a positive start to FY24. Identifying targets that meet our non-negotiable investment criteria, our speed of deal execution and tenacity of operational and financial integration defines our M&A strategy, which remains a key pillar of growth for Supreme.

As a business, we are actively engaged in the debate to make the UK tobacco free and welcomed the UK Government's recent "Achieving Smoke-free 2030" initiative, particularly its recognition of vaping as "the most effective" tool for smoking cessation. We fully support the new policies adopted, including the proposed launch of a fully funded national 'swap to stop' scheme to provide vapes as a first-line quit aid in local stop smoking services, and are encouraged by the robust plans to penalise brands and manufacturers who actively target young vapers.

Our people remain one of the Company's most valuable assets. Internally, we responded rapidly to the emergence of the cost-of-living crisis, announcing in September 2022 permanent and out-of-cycle pay rises for all staff earning less than £30,000. 70% of the workforce qualified, with around 50% of staff receiving 10% pay rises. To finance this scheme and simultaneously keep our profit commitments to our shareholders, I sacrificed my salary for the second half of FY23. We have an excellent track record of retaining talent, and by supporting our employee base, particularly those most affected by the crisis, I am confident we can continue to be recognised as a great place to work.

We are proud of the attractive portfolio of great value products we have developed and look forward to continuing to supply an extensive customer base extending over the private and public sectors. The Board firmly believes that the Company can achieve its strategic aspirations as we aim to continue on our upward growth trajectory in FY24 and beyond.

Operational Review

The Group has continued to evolve its business model in the period, adding new customers and brands alongside broadening the reach of our existing brands and products across our established customer base. Given the majority of our brands are either licensed, own-brand or acquired, as well as white-labelled, Supreme has established incredibly loyal and long-term customer partnerships.

During FY23, we agreed a lease for a new warehouse and office site proximal to our existing facilities, further consolidating Manchester as the focal point of our business. Once activities commence from the hub, which is projected to occur in FY24, we will be able to increase the efficiency of our overarching integrated platform, streamline both storage and distribution and accommodate future bolt-on M&A.

With this strong platform central to our business, management will continue to focus on the following strategic growth drivers, namely:

· continue to explore and execute on complementary earnings enhancing acquisitions;

· further leverage cross-sell opportunities to expand our customer footprint and average revenue per customer;

· continue to explore and develop new product verticals that complement Supreme's customer base, focused on a high quality and good value consumer proposition;

· increase manufacturing efficiencies through further economies of scale and bringing the manufacture of certain products in-house;

· enhance online distribution and services to further grow our B2B and D2C sales channels; and

· expand our international footprint through existing customer relationships and strategic acquisitions.

Vaping

The Group's Vaping division delivered a record performance in FY23, underpinned by a combination of significant organic growth and the completion and integration of a number of earnings enhancing acquisitions. The division nearly doubled revenues, generating £76.1 million (FY22: £43.6 million), an increase of 75% year-on-year, with incremental revenue from the acquisitions of Liberty Flights and Cuts Ice constituting 40% of the growth.

Our core 88vape brand delivered another outstanding performance and, as we continue to expand our product range and optimise our D2C online sales capabilities, we anticipate the brand's growth will accelerate in the medium to long term. Driven by retailer and consumer demand, and to complement our existing hero e-liquid ranges, Supreme launched a range of disposable vapes during FY23 which has generated almost £12 million in incremental revenue in its first year. Pleasingly, our contract with UK prisons also reported growth of 25% year-on-year following further competitive displacement and increased volumes.

Following a seamless process, the Liberty Flights and Cuts Ice businesses were integrated into the wider Group, which is testament to the hard work and commitment of the Supreme team and further supports our track record of successful M&A integration. In addition, we also completed the acquisition of Superdragon in March 2023, an experienced manufacturer of e-liquids. Collectively, the vaping acquisitions have significantly scaled the Group, providing Supreme with complementary owned brands, access to new customer bases and territories, wider manufacturing know-how and state-of-the-art technology. Most importantly, all the acquired vaping brands share Supreme's ethos: to support a tobacco-free UK by offering adults credible, affordable and safer alternatives for nicotine consumption.

Acquired as part of the Cuts Ice transaction, we announced the disposal of the intellectual property of T-Juice to an affiliate of leading French e-cigarette and e-liquids wholesaler, LVP, in March 2023. Supreme retains the exclusive manufacturing rights to T-Juice as part of this arrangement and expects to generate around £3 million in annualised revenue. In addition to the ongoing manufacturing revenue, the deal generated £4 million of cash for the Group on completion.

Supreme has consolidated its position as a market-leading manufacturer, distributor and brand owner in the vaping sector, and continues to explore additional opportunities to grow both its market share in an ever-expanding industry boosted by increasing Government support.

Lighting

As previously reported, the Group's Lighting category experienced a challenging year of trading, with customer overstocking issues, alongside well-documented global supply chain and transportation problems impacting numerous businesses in the industry, with a resulting 43% reduction in revenue to £15.4 million (FY22: £27.0 million). Encouragingly, Supreme has since stabilised the category, and the Company expects it to recover across FY24 and FY25.

The category has retained all its listings, whilst every existing customer relationship remains in-tact, facilitating the recovery process in the medium to long term. In addition, our largest retail customers have now provided us with access to their EPOS and stockholding data, previously prohibited, allowing us to measure stock levels and forecast demand more accurately. This initiative potentially de-risks this category going forward with the expectation that the FY23 setback was both temporary and very unlikely to reoccur without warning.

Commercially, the Group secured an extension to our existing licenses with Energizer and Eveready, which is now valid until 2030, as we proactively focused on strengthening existing license agreements with well-known global brands and retailers. A new licence agreement has also been agreed with Black and Decker, a trusted brand for retail customers seeking an alternative to their own label products, whilst the integration of Vendek has also presented significant commercial opportunities.

Looking ahead, Supreme is committed to building on the significant recovery progress made in the second half of the financial year and we anticipate the division will deliver an improved performance across FY24.

Sports Nutrition & Wellness

The Sports Nutrition & Wellness category delivered revenues of £16.7 million in FY23 (FY22: £15.9 million), which was a solid performance. During FY23, the Group unveiled a new-look Sci-MX, Supreme's principal powders brand. Relaunching the entire range has delivered strong sales momentum, whilst the Group also brought manufacturing in-house to increase profitability in the longer term and streamline the supply chain following the acquisition of the brand in FY22.

Protein powders represent approximately 70% of the segment's revenue and significant inflationary pressures impacting powders, particularly whey, have inevitably impacted the performance of the category. Supreme took a prudent approach to overcoming these macroeconomic headwinds by electing to support retailers through this price hike to protect long-term relationships and future trading aspirations in what is a fast-growing market.

Alongside investment in marketing and advertising initiatives, we launched exciting products across a number of our key brands, including new Battle Bites protein bars and other nutritional snacks.

Vitamins, which continue to operate from a low base, traded in line with expectations, and we continued to roll-out new vitamins pouches and supplements to expand our great value digital-only Sealions range.

As raw material price pressures ease, Supreme is focused on increasing manufacturing capacity for the category in FY24 and remains well-placed to capitalise on strong consumer demand for a diverse range of sports nutrition and wellness products.

Batteries

The Batteries category delivered another year of solid profitable growth, generating revenue of £39.5million in FY23 (FY22: £34.9 million), 13% growth. Batteries remain a sticky consumer product which, for several retailers, are essential items on their stocklists. Consequently, Supreme has been able to establish long-term customer relationships through this channel, generating opportunities to cross-sell additional products from our portfolio. This highlights not only the integral role the division plays in Supreme's overarching growth strategy, but also the effectiveness of the Group's vertically integrated platform in attracting customers across multiple verticals.

The backbone of the business and requiring minimal costs to serve, Supreme is focused on enhancing its battery distribution functions and bolstering existing relationships with retailers to generate increased revenues from the category.

Outlook

Supreme remains a highly cash-generative business, underpinned by a trusted vertically integrated platform that facilitates new business momentum and ensures products efficiently reach end markets. Continued investment in both our people and facilities demonstrates our commitment to our long-term growth plans, and we look ahead with confidence as we strive to deliver on our strategic priorities.

Looking at FY24, the Group expects to maintain its strong growth trajectory, delivering another strong year of profitable growth across all product categories. We have seen a very strong start to FY24 with all areas of the business performing very well.

In addition, I am delighted to have recently been appointed as master distributor for Elfbar and Lost Mary, two of the UK's biggest vaping brands. This appointment recognises our unrivalled and scaled UK distribution capabilities as well as our expertise in the vaping sector, particularly with reference to governance and compliance.

Accelerated trading in the core business combined with this vaping distribution opportunity means that we expect trading for the year ended 31 March 2024 to be significantly ahead of previous market expectations⁵

Sandy Chadha

Chief Executive Officer

4 July 2023

Chief Finance Officer's Review

I am pleased to present these financial results for the year ended 31 March 2023. Overall, the Group delivered a robust financial performance; revenue increased, the balance sheet strengthened and the Group's cash reserves grew. In addition to a pleasing performance from our core business, we completed and integrated two earnings-enhancing acquisitions with a third acquisition completed on the final day of the financial year. The table below summarises the key financial measures and the comparisons to prior year. The commentary in this review references alternative performance measures which are described as 'Adjusted', meaning they exclude share-based payment charges, fair value movements on non-hedge accounted derivatives and non-recurring items referred to in Note 7 to the Financial Statements. In addition, this review also references 'net debt' which is defined as closing cash, as reported on the balance sheet, net of borrowings, as defined in Note 20.

Revenue

Revenue for FY23 was £155.6 million (FY22: £130.8 million), an increase of 19%, the drivers for which have been presented in the product categories below. 52% of the growth, £12.8 million, came from acquisitions whilst the remainder of the growth, £12.0 million, came from the core business. Furthermore, this core business growth of £12.0 million was the net effect of a reduction in Lighting revenue of £11.6 million combined with revenue growth across the remainder of the core business of £23.6 million.

Revenue by product category

Revenue for Batteries was £39.5 million in FY23 (FY22: £34.9 million), growth of 13%, arising from a combination of increased volume and price. This increased volume, at a time of overall market decline, was especially pleasing and highlights the strength of Supreme's offering as well as the resilience of its customers. This category grew significantly during COVID and was initially expected to reverse, which makes the continued growth a particularly pleasing result.

Revenue for Lighting was £15.4 million (FY22: £27.0 million), a fall of 43% in what has been a challenging year, and the first year of revenue contraction since the category commenced trading over 15 years ago. This reduction was driven from a slowdown in consumer spending and retailer overstocking in FY22. Importantly, we have retained all customers and retail listings and we are confident that our collaborative approach with customers during this period has cemented our longer-term relationships with these retailers. The category is expected to recover across FY24 and FY25.

Revenue for Vaping was £76.1 million (FY22: £43.6 million), growth of 75%. £12.8m (40% of the growth) came from the acquisitions of Liberty Flights and Cuts Ice and a third acquisition, Superdragon, was completed on the final day of FY23 and has already added to FY24 earnings. Aside from acquisitions, the category reported organic growth of £19.7 million, arising from the launch of a range of disposable vapes as well as strong growth in Supreme's contract with UK prisons following competitive displacement and increased volumes. Importantly, the revenue from the launch of disposable vapes has not had any impact on the sale of the 10ml eliquid product, the category's hero product, which has continued to gain market share.

Revenue for Sports Nutrition & Wellness was £16.7 million (FY22: £15.9 million), growth of 5%, a period characterised by record levels of raw material inflation. The reduction in gross profit as a percentage of sales from 22% in FY22 to 16% in FY23 arose because Supreme chose to absorb some of this price inflation into its own margin, temporarily, in the spirit of fair, honest, low pricing. Whey prices have now started to fall and the gross profit percentage is expected to recover accordingly in FY24.

Revenue from its various 'Other' channels came to £7.8 million (FY22: £9.4 million) a direct result of the rationalisation of the category to redeploy working capital, resource and warehouse space to more higher margin areas of the business.

Gross profit

Gross profit for FY23 was £40.9 million (FY22: £38.5 million), growth of 6%. As a percentage of revenue, gross profit was 26% (FY22: 29%). This reduction of 3% was largely a result of sales mix within categories. In Vaping in particular this was driven by the increased focus on hardware sourced from the Far East in the form of disposable and pod vapes and in Lighting this was due to the sharp reduction in lighting sourced from the Far East and shipped direct to customers in the UK and Europe. Gross profit was also affected by the inflationary price pressures that arose in Sports Nutrition & Wellness and the temporarily lower margins arising from the acquisitions before their operations were integrated into the Supreme platform.

Adjusted EBITDA¹

Administrative expenses, excluding depreciation (£2.2 million), amortisation (£0.9 million) and Adjusted items within administrative expenses (£3.6 million) were £21.5 million (FY22: £17.5 million), an increase of £4.0 million.

The largest contributor to this increase was the incremental overheads associated with Liberty Flights (£2.8 million), which was earnings-accretive at an EBITDA level. Secondly, selling costs (that typically increase in line with sales) contributed £0.6 million to the increase. The balance arose from inflationary increases largely in transport, utilities and people costs via the out-of-cycle pay-rise announced in September in response to the cost of living crisis.

As a result, Adjusted EBITDA¹ decreased by £1.7 million (8%) in the year to £19.4 million (FY22: £21.1 million).

Adjusted Items

Adjusted Items were £0.8 million compared to £1.1 million the year before. These costs related to share-based payment charge of £1.5 million (FY22: £1.7 million), £1.1 million charge in relation to fair value movements on financial derivatives (FY22: £1.0 million credit) and £1.0 million of non-recurring items relating to the acquisitions and subsequent integrations of the business acquired during the year, offset by a credit of £2.8 million relating to the profit on disposal of the T Juice brand. The £1.0 million of acquisition and integrations costs arose principally from the termination of all Cuts Ice staff (£0.6 million) and the closure costs relating to the two Cuts Ice London-based operating sites (£0.2 million), offset by a credit of £0.3 million in respect of accrued but unpaid contingent consideration in respect of the acquisition of Vendek that completed in FY21.

The Board believes that by adjusting these items from profitability, it is able to understand the underlying performance of the business more clearly and further information pertaining to these items can be found in Note 7 to these financial statements.

Finance costs

Finance costs were £1.0 million in the year (FY22: £0.7 million), split between interest arising from borrowings in the year of £0.8 million plus the interest relating to the lease liabilities under IFRS16 (£0.2 million).

Taxation

Total tax charge in the year was £2.5 million (FY22: £2.6 million), giving rise to an effective tax rate of 17% (FY22: 16%).

Profit after tax and Earnings per share

Profit after tax was £12.0 million compared to £13.7 million in FY22, a reduction of £1.7 million. As a result, earnings per share decreased by 13% to 10.3p (FY22: 11.8p) and on a fully diluted basis decreased from 11.4p to 9.7p.

On an adjusted profit after tax basis, which we consider to be a better measure of performance, adjusted earnings (as calculated in note 11) were £13.8 million (FY22: £15.0 million) and adjusted earnings per share³ was 11.8p (FY22: 12.8p).

Dividends

The Group's dividend policy is to pay an annual amount equivalent to around 25% of net profit. In January 2023 the Group paid an interim dividend of 0.8p per share and the Directors will recommend a final dividend of 2.2p per share at the 2023 Annual General Meeting to be held on the 26 September 2023. This will be paid on 29 September 2023 to shareholders on the register at the close of business on 1 September 2023. The ex-dividend date will be 31 August 2023.

Cash flow

The Group generated £19.3 million of operating cash in FY23, nearly doubling the level of operating cash generated in FY22; the result of a tightly managed base of working capital.

Specifically in reference to the acquisitions, £7.5 million related to the acquisition of Liberty Flights (with a further £2.0 million of deferred consideration payable in FY24 plus further consideration contingent on performance, expected to be £2.2 million) and £2.6 million related to the acquisition of Cuts Ice. The T-Juice brand (acquired as part of the Cuts Ice acquisition and valued at £1.2 million at the time) was then disposed of 7 months later for £4.0 million, resulting in a profit on disposal of £2.8 million.

In respect of financing, on 31 March 2022 the Group committed to a £25 million revolving credit facility ("RCF") with HSBC. Initially, the facility was used to settle existing bank and related party borrowings and then was subsequently used to finance acquisitions. At its peak, the Group had drawn £18.4 million against the facility. In the second half of the year much of this was repaid with cash generated from trading activities and at year end the balance on the facility was £4.3 million drawn with the remainder unutilised. In addition, the Group also had access to an £8.5 million working capital facility which was also entirely undrawn at year end. Together with reported cash of £7.5 million (FY22: £3.9 million) and deferred and contingent consideration of £4.1 million, the Group's Adjusted net cash⁴ position was £3.2 million (FY22: £1.9 million Adjusted net debt⁴). The IFRS16 lease liability increased from £2.2 million to £15.0 million during the year, wholly in relation to the 15 year lease signed for 'Ark', the facility that will become the Group's principal storage and distribution centre in FY24.

Across the RCF and the working capital facility, there was £30 million of undrawn borrowings facilities on 31 March 2023; providing significant liquidity to finance M&A or organic growth in the form of working capital in the future.

Net debt

Use of non-GAAP measures in the Group financial statements

Certain measures have been used to increase understanding of the Group's Report and Accounts. These measures are not defined under IFRS and therefore may not be directly comparable with adjusted measures presented by other companies. The non-GAAP measures are not intended to be a substitute for or superior to any IFRS measure of performance; however they are considered by management to be important measures used in the business for assessing performance. The non-GAAP measures used in this strategic review and more widely in this Annual Report are defined in the footnotes below and set out in Note 7 to these financial statements.

Suzanne Smith

Chief Finance Officer

4 July 2023

²Adjusted Profit before tax means profit before tax and Adjusted items (as defined in Note 7 of the financial statements) Adjusted items include share-based payments charge, fair value movements on non-hedge accounted derivatives and non-recurring items

³Adjusted EPS means Earning per share, where Earnings are defined as profit after tax but before amortisation of acquired intangibles and Adjusted items (as defined in Note 7 of the financial statements). Adjusted items include share based payments, fair value movements on non-hedge accounted derivatives and non-recurring items.

⁴Adjusted net debt means net debt as defined in Note 29 to these financial statements excluding the impact of IFRS16.

Consolidated Statement of Comprehensive Income

for the Year Ended 31 March 2023

		Year Ended 31 March 2023	Year Ended 31 March 2022
	Note	£'000	£'000

Revenue	5	155,612	130,789
Cost of sales	6	(114,758)	(92,272)
Gross Profit		40,854	38,517

Profit on disposal of Cuts Ice trademarks	7	2,787	-
Administration expenses	6	(28,192)	(21,498)
Operating profit		15,449	17,019

Adjusted EBITDA¹		19,392	21,055
Depreciation	13 & 21	(2,200)	(2,563)
Amortisation	12	(915)	(378)
Adjusted items	7	(828)	(1,095)

Operating profit		15,449	17,019

Finance income	9	25	-
Finance costs	9	(1,037)	(693)
Profit before taxation		14,437	16,326

Income tax	10	(2,469)	(2,579)
Profit for the year		11,968	13,747

Other comprehensive expense
Items that may be reclassified to profit or loss
Exchange differences on translation of foreign operations		101	(32)
Total other comprehensive income/(expense)		101	(32)
Total comprehensive income		12,069	13,715

Earnings per share - basic	11	10.3p	11.8p
Earnings per share - diluted	11	9.7p	11.4p

Note 1: Adjusted EBITDA, which is defined as operating profit before depreciation, amortisation and Adjusted items (as defined in Note 7) is a non-GAAP metric used by management and is not an IFRS performance measure.

All results derive from continuing operations.

Consolidated Statement of Financial Position

as at 31 March 2023

		As at 31 March 2023	As at 31 March 2022
	Note	£'000	£'000
Non-current assets
Assets
Goodwill and other intangibles	12	15,281	3,704
Property, plant and equipment	13	5,238	2,557
Right of use asset	21	15,577	2,116
Deferred tax asset	15	-	1,312
Investments	14	7	7
Total non-current assets		36,103	9,696

Current assets
Inventories	16	25,606	25,898
Trade and other receivables	17	20,899	19,035
Forward contract derivative	22.9	-	467
Cash and cash equivalents	18	7,536	3,926
Total current assets		54,041	49,326
Total assets		90,144	59,022

Liabilities

Current liabilities
Borrowings	20	5,026	6,665
Trade and other payables	19	26,117	17,296
Forward contract derivative	22.9	652	-
Income tax payable		2,536	1,299
Total current liabilities		34,331	25,260
Net current assets		19,710	24,066

Borrowings	20	14,293	1,294
Deferred tax liability	15	789	156
Provisions	21	775	-
Total non-current liabilities		15,857	1,450
Total liabilities		50,188	26,710
Net assets		39,956	32,312

Equity
Share capital	23	11,732	11,663
Share premium		7,427	7,231
Merger reserve		(22,000)	(22,000)
Share-based payments reserve		3,043	2,368
Retained earnings		39,754	33,050
Total equity		39,956	32,312

The notes are an integral part of these financial statements.

The financial statements were approved by the Board of Directors and authorised for issue on 4th July 2023, and were signed on its behalf by:

S Smith

Director

Registered number: 05844527

Consolidated Statement of Changes in Equity

for the Year Ended 31 March 2023

	Share Capital	Share Premium	Merger reserve	Share-based payments reserve	Retained earnings	Total equity
	£'000	£'000	£'000	£'000	£'000	£'000
As at 1 April 2021	11,650	7,195	(22,000)	75	21,901	18,821

Profit for the year	-	-	-	-	13,747	13,747
Other comprehensive expense	-	-	-	-	(32)	(32)
Total comprehensive income for the year	-	-	-	-	13,715	13,715

Transactions with shareholders:
Issue of shares	13	36	-	-	-	49
Employee share schemes - value of employee services	-	-	-	1,452	-	1,452
Deferred tax on share-based payment charge	-	-	-	841	-	841
Dividends	-	-	-	-	(2,566)	(2,566)
	13	36	-	2,293	(2,566)	(224)
As at 31 March 2022	11,663	7,231	(22,000)	2,368	33,050	32,312

Profit for the year	-	-	-	-	11,968	11,968
Other comprehensive income	-	-	-	-	101	101
Total comprehensive income for the year	-	-	-	-	12,069	12,069

Transactions with shareholders:
Issue of shares	69	196	-	-	-	265
Employee share schemes - value of employee services	-	-	-	1,283	-	1,283
Deferred tax on share-based payment charge	-	-	-	(608)	-	(608)
Dividends	-	-	-	-	(5,365)	(5,365)
	69	196	-	675	(5,365)	(4,425)
As at 31 March 2023	11,732	7,427	(22,000)	3,043	39,754	39,956

Consolidated Statement of Cash Flows

for the Year Ended 31 March 2023

		Year Ended 31 March 2023	Year Ended 31 March 2022
	Note	£'000	£'000
Net cash flow from operating activities
Profit for the year		11,968	13,747
Adjustments for:
Amortisation of intangible assets	12	915	378
Depreciation of tangible assets	13	1,268	1,748
Depreciation of right of use assets	21	932	815
Finance income		(25)	-
Finance costs	9	982	404
Amortisation of capitalised finance costs	9	55	289
Income tax expense	10	2,469	2,579
Gain on disposal of intangible fixed assets	7	(2,787)	-
Movement on forward foreign exchange contracts	22.9	1,119	(1,026)
Share based payments expense	24	1,460	1,663
Working capital adjustments (net of acquired on business combinations)
Decrease/(increase) in inventories		2,920	(4,937)
Increase in trade and other receivables		(671)	(2,226)
Increase in trade and other payables		(27)	2,498
Increase in provisions		349	-
Taxation paid		(1,652)	(4,161)
Net cash from operations		19,275	11,771
Cash flows used in investing activities
Purchase of intangible fixed assets	12	(23)	(1,454)
Purchase of property, plant and equipment	13	(1,254)	(1,296)
Purchase of business combinations net of cash acquired	25	(10,055)	(1,040)
Proceeds from sale of property, plant and equipment		1	378
Proceeds from sale of intangible fixed assets		4,018	-
Payment of deferred consideration		(270)	-
Finance income received		25	-
Net cash used in investing activities		(7,558)	(3,412)
Cash flows used in financing activities
Repayment of long term loans	20	(3,984)	(6,470)
Repayment of related party loans		(1,779)	(1,613)
Repayments of RCF facility		(14,000)	-
Drawdowns of RCF facility		18,418
Issue of options or share capital		265	49
Payment of deferred consideration		-	(66)
Dividends paid		(5,365)	(2,566)
Finance costs paid		(776)	(285)
Interest paid on leases		(153)	(118)
Lease payments		(834)	(837)
Net cash used in financing activities		(8,208)	(11,906)

Net increase/(decrease) in cash and cash equivalents		3,509	(3,547)
Cash and cash equivalents brought forward		3,926	7,505
Effects of exchange rate changes		101	(32)
Cash and cash equivalents carried forward		7,536	3,926

Cash and cash equivalents	18	7,536	3,926
		7,536	3,926

Notes to the Group Financial Statements

for the Year Ended 31 March 2023

1. Basis of preparation

Supreme PLC ("the Company") is a public company limited by shares, registered in England and Wales and domiciled in the UK, with company registration number 05844527. The principal activity is the manufacture (vaping and sports nutrition & wellness only) and wholesale distribution of batteries, lighting, vaping, sports nutrition & wellness and branded household consumer goods. The registered office is 4 Beacon Road, Ashburton Park, Trafford Park, Manchester, M17 1AF.

The financial information set out in this preliminary announcement does not constitute statutory accounts as defined by section 434 of the Companies Act 2006.

These Group financial statements have been prepared on a going concern basis under the historical cost convention, modified for the revaluation of certain financial instruments; in accordance with UK-adopted International Accounting Standards and with the requirements of the Companies Act 2006 as applicable to companies reporting under those standards.

The results for the year ended 31 March 2023 have been extracted from the full accounts of the Group for that year which received an unqualified auditor's report and which have not yet been delivered to the Registrar of Companies. The financial information for the year ended 31 March 2022 is derived from the statutory accounts for that year, which have been delivered to the Registrar of Companies. The report of the auditor on those filed accounts was unqualified. The accounts for the year ended 31 March 2023 and 31 March 2022 did not contain a statement under s498 (1) to (4) of the Companies Act 2006. The statutory accounts for the year ended 31 March 2023 will be posted to shareholders at least 21 days before the Annual General Meeting and made available on our website www.supreme.co.uk and on request by contacting the Company Secretary at the Company's Registered Office.

The Directors have prepared this financial information on the fundamental assumption that the Group is a going concern and will continue to trade for at least 12 months following the date of approval of the financial information.

The principal accounting policies adopted are set out below.

2. Summary of significant accounting policies

The principal accounting policies adopted are set out below.

2.1 Basis of consolidation

The consolidated financial statements present the results of the Company and its own subsidiaries as if they form a single entity. Intercompany transactions and balances between Group companies are therefore eliminated in full.

The Group financial statements incorporate the results of business combinations using the acquisition method. In the Consolidated Statement of Financial Position, the acquiree's identifiable assets, liabilities and contingent liabilities are initially recognised at their fair values at the acquisition date. The results of acquired operations are included in the Consolidated Statement of Comprehensive Income from the date on which control is obtained. They are deconsolidated from the date control ceases. The merger reserve arose on a past business combination of entities that were under common control. The merger reserve is the difference between the cost of investment and the nominal value of the share capital acquired.

Notes to the Group Financial Statements continued

for the Year Ended 31 March 2023

2. Summary of significant accounting policies (continued)

2.2 New standards, amendments and interpretations

New and amended standards and adopted by the Group

The Group has applied the following standards and amendments for the first time for its annual reporting period commencing 1 April 2022:

Standards and interpretations	Effective from
Annual Improvements to IFRS Standards 2018-2020	1 April 2022
Narrow scope amendments to IFRS 3, IAS 16 and IAS 37	1 April 2022

The amendments listed above do not have any impact on the amounts recognised in prior periods and are not expected to significantly affect current or future periods.

New standards and interpretations not yet adopted

Certain new accounting standards and interpretations have been published that are not mandatory for 31 March 2023 reporting periods and have not been early adopted by the Group. These standards are not expected to have a material impact on the entity in the current or future reporting periods and on foreseeable future transactions:

Standards and interpretations	Effective from
IFRS 17 Insurance Contracts	1 April 2023
Classification of Liabilities as Current or Non-current - Amendments to IAS 1	1 April 2023
Disclosure of Accounting Policies - Amendments to IAS 1 and IFRS Practice Statement 2	1 April 2023
Definition of Accounting Estimates - Amendments to IAS 8	1 April 2023
Deferred Tax related to Assets and Liabilities arising from a Single Transaction - Amendments to IAS 12	1 April 2023
Amendments to IAS 1, "Presentation of financial statements" and classification of liabilities	1 April 2024
Amendments to IAS 1, "Presentation of financial statements" on non-current liabilities with covenants	1 April 2024
Amendments to IFRS 16, "Leases" Lease Liability in a sale and leaseback	1 April 2024

Judgements made by the Directors in the application of these accounting policies that have a significant effect on these financial statements together with estimates with a significant risk of material adjustment in the next year are discussed in Note 4.

2.3 Going concern

In assessing the appropriateness of adopting the going concern basis in the preparation of these financial statements, the Directors have prepared cash flow forecasts and projections for the two-year period to 31 March 2025. The forecasts and projections, which the Directors consider to be prudent, have been further sensitised by applying reductions to revenue and profitability, to consider downside risk. Under both the base and sensitised case the Group is expected to have headroom against covenants, which are based on interest cover and net leverage, and a sufficient level of financial resources available through existing facilities when the future funding requirements of the Group are compared with the level of committed available facilities.

In assessing the going concern basis, the Directors have also considered the ongoing conflict in Ukraine and the resulting sanctions imposed on Russia by governments worldwide, the increased cost of borrowing and the ongoing cost of living crisis taking place in the UK, all of which have been reflected in this forecast.

Notes to the Group Financial Statements continued

for the Year Ended 31 March 2023

2. Summary of significant accounting policies (continued)

2.3 Going concern (continued)

· Whilst the Ukraine crisis initially imposed sourcing pressure on Supreme for certain ingredients (specifically sunflower lecithin and wheat protein), alternative sources and replacement ingredients were secured in early FY23 and therefore the risk to Supreme at present is considered minimal and managed.

· Whilst the Group's debt facilities are priced at a variable rate (SONIA + a margin) the Group's current positive leverage ratio (i.e. having more cash than bank borrowings), meaning that the Group could repay the borrowings in full means that Supreme's exposure to this increased cost is limited. Should the Group increase its level of bank borrowings during the forecast period (likely to be triggered by M&A) then of course this increased cost of borrowing would impact the Group (albeit expected to be offset by the incremental earnings generated by any M&A target).

· Historically Supreme has been a net beneficiary in periods of economic downturn, owing to the fact more than half of its revenue is derived from the discount retail sector which typically trades buoyantly during these periods (for prudence this has not been assumed in the forecast). The inflationary cost increases (specifically over salary costs, energy and transport) have been specifically factored into the cost base throughout for the forecast period.

Based on this, the Directors are satisfied that the Group has adequate resources to continue in operational existence for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the Group and Company financial statements.

2.4 Currencies

Functional and presentational currency

Items included in the Group financial statements are measured using the currency of the primary economic environment in which the Company operates ("the functional currency") which is UK sterling (£). The Group financial statements are presented in UK sterling.

Transactions and balances

Foreign currency transactions are translated into the functional currency using a standard exchange rate for a period if the rates do not fluctuate significantly. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation at year-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in the statement of comprehensive income. Non-monetary items that are measured in terms of historical cost in a foreign currency are not retranslated.

Group companies

The results and financial position of foreign operations (none of which has the currency of a hyper-inflationary economy) that have a functional currency different from the presentation currency are translated into the presentation currency as follows:

· assets and liabilities for each statement of financial position presented are translated at the closing rate at the date of that statement of financial position;

· income and expenses for each statement of comprehensive income are translated at average exchange rates (unless this is not a reasonable approximation of the cumulative effect of the rates prevailing on the transaction dates, in which case income and expenses are translated at the dates of the transactions); and

· all resulting exchange differences are recognised in other comprehensive income.

Notes to the Group Financial Statements continued

for the Year Ended 31 March 2023

2. Summary of significant accounting policies (continued)

2.5 Revenue recognition

Revenue solely relates to the sale of goods and arises from the wholesale distribution and online sales of batteries, lighting, vaping sports nutrition & wellness and other consumer goods.

To determine whether to recognise revenue, the Company follows the 5-step process as set out within IFRS 15:

1. Identifying the contract with a customer.

2. Identifying the performance obligations.

3. Determining the transaction price.

4. Allocating the transaction price to the performance obligations.

5. Recognising revenue when/as performance obligation(s) are satisfied.

Revenue is measured at transaction price, stated net of VAT, and other sales related taxes. Rebates to customers take the form of volume discounts, which are a type of variable consideration, and the transaction price is constrained to reflect the rebate element. The transaction price equates to the invoice amount less an estimate of any applicable rebates and promotional allowances that are due to the customer. Rebate accruals are recognised under the terms of these agreements, to reflect the expected promotional activity and our historical experience. These accruals are reported within trade and other payables.

Revenue is recognised at a point in time as the Company satisfies performance obligations by transferring the promised goods to its customers as described below. At any point in time where such obligations haven't been met but the customer has been invoiced, revenue is deferred, as disclosed in note 19. Variable consideration, in the form of rebates, is also recognised at the point of transfer, however the estimate of variable consideration is constrained at this point and released once it is highly probable there will not be a significant reversal.

Contracts with customers take the form of customer orders. There is one distinct performance obligation, being the distribution of products to the customer, for which the transaction price is clearly identified. Revenue is recognised at a point in time when the Group satisfies performance obligations by transferring the promised goods to its customers, i.e. when control has passed from the Group to the customer, which tends to be on receipt by the customer. In respect of certain direct shipments control passes when an invoice is raised, payment received, and title formally transferred to the customer; at which point the customer has the risks and rewards of the goods.

2.6 Goodwill

The carrying value of goodwill has arisen following the acquisition of subsidiary entities. Such goodwill is subject to an impairment review, both annually and when there is an indication that the carrying value may be impaired. Any impairment is recognised immediately in the Statement of Comprehensive Income and is not reversed.

2.7 Other intangible assets

Other intangible assets that are acquired by the Group are stated at cost less accumulated amortisation and accumulated impairment losses.

The amortisation is charged on a straight-line bases as follows:

Domain name - 10%

Trademarks - 10%

Customer relationships - 20%

Trade names - 20%

Computer software - 50%

Know how - 10%

Notes to the Group financial statements continued

for the Year Ended 31 March 2023

2. Summary of significant accounting policies (continued)

2.8 Property, plant and equipment

Property, plant and equipment are stated at cost less accumulated depreciation and any impairment losses. Cost includes the original purchase price of the asset and the costs attributable to bringing the asset to its working condition for its intended use. Depreciation is charged so as to write off the costs of assets over their estimated useful lives, on a straight-line basis starting from the month they are first used, as follows:

Land- 0%

Assets under construction - 0%

Plant and machinery - 25%

Fixtures and fittings - 25%

Motor vehicle - 25%

Computer equipment - 33%

Buildings - 2%

The gain or loss arising on the disposal of an asset is determined as the difference between the sales proceeds and the carrying amount of the asset and is recognised in the Statement of Comprehensive Income.

At each reporting date, the Company reviews the carrying amounts of its property, plant and equipment assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).

Notes to the Group financial statements continued

for the Year Ended 31 March 2023

2. Summary of significant accounting policies (continued)

2.9 Inventories

Inventories are valued using a first in, first out method and are stated at the lower of cost and net realisable value. Cost includes expenditure incurred in the normal course of business in bringing the products to their present location and condition.

At the end of each reporting period inventories are assessed for impairment. If an item of inventory is impaired, the identified inventory is reduced to its selling price less costs to complete and sell and an impairment charge is recognised in the income statement. Where a reversal of the impairment is recognised the impairment charge is reversed, up to the original impairment loss, and is recognised as a credit in the income statement.

2.10 Income tax

The tax expense or credit represents the sum of the tax currently payable or recoverable and the movement in deferred tax assets and liabilities.

(a) Current income tax

Current tax is based on taxable income for the year and any adjustment to tax from previous years. Taxable income differs from net income in the statement of comprehensive income because it excludes items of income or expense that are taxable or deductible in other years or that are never taxable or deductible. The calculation uses the latest tax rates for the year that have been enacted or substantively enacted by the dates of the Statement of Financial Position.

(b) Deferred tax

Deferred tax is calculated at the latest tax rates that have been substantively enacted by the reporting date that are expected to apply when settled. It is charged or credited in the Statement of Comprehensive Income, except when it relates to items credited or charged directly to equity, in which case it is also dealt with in equity.

Deferred tax is the tax expected to be payable or recoverable on differences between the carrying amounts of assets and liabilities in the Group financial statements and the corresponding tax bases used in the computation of taxable income, and is accounted for using the liability method. It is not discounted.

Deferred tax liabilities are generally recognised for all taxable temporary differences and deferred tax assets are recognised to the extent that it is probable that taxable income will be available against which the asset can be utilised. Such assets are reduced to the extent that it is no longer probable that the asset can be utilised.

Deferred tax assets and liabilities are offset when there is a right to offset current tax assets and liabilities and when the deferred tax assets and liabilities relate to taxes levied by the same taxation authority on either the same taxable entity or different taxable entities where there is an intention to settle the balances on a net basis.

2.11 Leases

The Company applies IFRS 16 in the Group financial statements. At inception of a contract, the Group assesses whether a contract is, or contains, a lease. A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration.

The Group recognises a right-of-use asset and a lease liability at the lease commencement date. The right-of-use asset is initially measured at cost, which comprises the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date, plus any initial direct costs incurred and an estimate of costs to restore the underlying asset, less any lease incentives received.

The right-of-use asset is subsequently depreciated using the straight-line method from the commencement date to the earlier of the end of the useful life of the right-of-use asset or the end of the lease term. In addition, the right-of-use asset is periodically reduced by impairment losses, if any, and adjusted for certain remeasurements of the lease liabilities.

Notes to the Group financial statements continued

for the Year Ended 31 March 2023

2. Summary of significant accounting policies (continued)

2.11 Leases (continued)

The lease liability is initially measured at the present value of lease payments that were not paid at the commencement date, discounted using the rate implicit in the lease. Where there is no rate implicit in the lease then the Group's incremental borrowing rate is used.

The lease liability is measured at amortised cost using the effective interest method. If there is a remeasurement of the lease liability, a corresponding adjustment is made to the carrying amount of the right-of-use asset, or is recorded directly in profit or loss if the carrying amount of the right of use asset is zero.

Short term leases and low value assets

The Group has elected not to recognise right-of-use assets and lease liabilities for short-term lease of machinery that have a lease term of 12 months or less or leases of low value assets. These lease payments are expensed on a straight-line basis over the lease term.

2.12 Payroll expense and related contributions

The Group provides a range of benefits to employees, including annual bonus arrangements, paid holiday arrangements and defined contribution pension plans.

Short term benefits, including holiday pay and other similar non-monetary benefits, are recognised as an expense in the period in which the service is received.

2.13 Share based payments

Where share options are awarded to employees, the fair value of the options at the date of grant is charged to profit or loss over the vesting period. Non-market vesting conditions are taken into account by adjusting the number of equity instruments expected to vest at each Statement of Financial Position date so that, ultimately, the cumulative amount recognised over the vesting period is based on the number of options that eventually vest. Market vesting conditions are factored into the fair value of the options granted. The cumulative expense is not adjusted for failure to achieve a market vesting condition.

The fair value of the award also takes into account non-vesting conditions. These are either factors beyond the control of either party (such as a target based on an index) or factors which are within the control of one or other of the parties (such as the Group keeping the scheme open or the employee maintaining any contributions required by the scheme).

Where the terms and conditions of options are modified before they vest, the increase in the fair value of the options, measured immediately before and after the modification, is also charged to the Statement of Comprehensive Income over the remaining vesting period.

Where equity instruments are granted to persons other than employees, the Statement of Comprehensive Income is charged with fair value of goods and services received.

2.14 Pension costs

The Company operates a defined contribution pension scheme for employees. The assets of the scheme are held separately from those of the Company. The annual contributions payable are charged to the statement of comprehensive income.

Notes to the Group financial statements continued

for the Year Ended 31 March 2023

2. Summary of significant accounting policies (continued)

2.15 Divisional reporting

Although revenue is grouped within five product categories, as the directors analyse revenue at this gross level, the directors do not analyse, monitor or review the Groups KPIS (being adjusted EBITDA and profit before tax) by product category. Due to this, the Group do not believe there are any IFRS 8 considerations around the requirement to report operating segments for reporting purposes.

2.16 Dividends

Dividends are recognised as a liability and deducted from equity at the time they are approved. Otherwise dividends are disclosed if they have been proposed or declared before the relevant financial statements are approved.

2.17 EBITDA and Adjusted EBITDA

Earnings before Interest, Taxation, Depreciation and Amortisation ("EBITDA") and Adjusted EBITDA are non-GAAP measures used by management to assess the operating performance of the Company. EBITDA is defined as profit before finance costs, tax, depreciation and amortisation. Adjusted items are excluded from EBITDA to calculate Adjusted EBITDA.

The Directors primarily use the Adjusted EBITDA measure when making decisions about the Company's activities as this provides useful information for shareholders on underlying trends and performance. As these are non-GAAP measures, EBITDA and Adjusted EBITDA measures used by other entities may not be calculated in the same way and hence are not directly comparable.

2.18 Adjusted items

The Company's income statement separately identifies Adjusted items. Such items are those that in the Directors' judgement need to be disclosed separately by virtue of either: their volatility year-on-year; their one-off nature; their size, their non-operating nature; or because the adjustment of a particular item is widely accepted and conducted by peers (to ensure comparability with other listed businesses). These may include, but are not limited to, professional fees and other costs directly related to refinancing, acquisitions and capital transactions, fair value movements on open forward contracts, share based payment charges, material impairments of inventories and gains/losses on disposal of intangible assets. In determining whether an item should be disclosed as an Adjusted item, the Directors consider quantitative and qualitative factors such as the frequency, predictability of occurrence and significance. This is consistent with the way financial performance is measured by management and reported to the Board.

2.19 Forward contracts derivatives

Financial assets and financial liabilities are recognised in the Group Statement of Financial Position when the Group becomes party to the contractual provisions of the instrument. Financial assets are de-recognised when the contractual rights to the cash flows from the financial asset expire or when the contractual rights to those assets are transferred. Financial liabilities are de-recognised when the obligation specified in the contract is discharged, cancelled or expired.

2.20 Trade and other receivables

Trade and other receivables are initially measured at transaction price less provisions for expected credit losses. The Group applies the IFRS 9 simplified approach to measuring expected credit losses which uses a lifetime expected loss allowance. This lifetime expected credit losses is used in cases where the credit risk on other receivables has increased significantly since initial recognition. In cases where the credit risk has not increased significantly, the Group measures the loss allowance at an amount equal to the 12-month expected credit loss. This assessment is performed on a collective basis considering forward-looking information.

Notes to the Group financial statements continued

for the Year Ended 31 March 2023

2. Summary of significant accounting policies (continued)

2.20 Trade and other receivables (continued)

IFRS 9's impairment requirements use forward-looking information to recognise expected credit losses - the 'expected credit loss (ECL) model'.

Recognition of credit losses is determined by considering a broad range of information when assessing credit risk and measuring expected credit losses, including past events, current conditions and reasonable and supportable forecasts that affect the expected collectability of the future cash flows of the instrument.

Measurement of the expected credit losses is determined by a probability-weighted estimate of credit losses over the expected life of the financial instrument.

Credit Insurance is also in place which also mitigates the credit risk in relation to the respective customer. This insurance is applied to most accounts over £5,000 with exception of proforma accounts and accounts agreed by the CEO, although some accounts are excluded from the credit insurance having been assessed by the Board on a cost-benefit analysis - these equate largely to the largest grocery retailers.

Interest income is recognised by applying the effective interest rate, except for short-term receivables when the recognition of interest would be immaterial.

2.21 Cash and cash equivalents

Cash and cash equivalents consist of cash on hand, demand deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of changes in value.

2.22 Trade and other payables

Trade and other payables are initially measured at their fair value and are subsequently measured at their amortised cost using the effective interest rate method; this method allocates interest expense over the relevant period by applying the "effective interest rate" to the carrying amount of the liability.

2.23 Invoice discounting facility

The Company has entered into an invoice discounting arrangement with the bank, where a proportion of the debts have been legally transferred but the benefits and risks are retained by the Company. Gross receivables are included within debtors and a corresponding liability in respect of any proceeds received from the bank that haven't yet been paid by customers are shown within liabilities. The interest element of the bank's charges are recognised as they accrue and included in the statement of comprehensive income within other interest payable. Once payments are received into the facility from customers, proceeds are transferred to the main bank account, which is presented within cashflow from working capital within the cashflow statement.

2.24 Borrowings

Interest-bearing overdrafts are classified as other liabilities. They are initially recorded at fair value, which represents the fair value of the consideration received, net of any direct transaction costs associated with the relevant borrowings. Borrowings are subsequently stated at amortised cost and finance charges are recognised in the Statement of Comprehensive Income over the term of the instrument using an effective rate of interest. Finance charges, including premiums payable on settlement or redemption, are accounted for on an accruals basis and are added to the carrying amount of the instrument to the extent that they are not settled in the period in which they arise. Borrowings are classified as current liabilities unless the Group has an unconditional right to defer settlement of the liability for at least 12 months after the reporting date.

2.25 Classification as debt or equity

Debt and equity instruments issued by the Group are classified as either financial liabilities or as equity in accordance with the substance of the contractual arrangements and the definitions of a financial liability and an equity instrument.

Notes to the Group financial statements continued

for the Year Ended 31 March 2023

2. Summary of significant accounting policies (continued)

2.26 Equity instruments

An equity instrument is any contract that evidences a residual interest in the assets of an entity after deducting all of its liabilities. Equity instruments issued by the Group are recognised at the proceeds received, net of direct issue costs. The excess of proceeds of a share issue over the nominal value is presented within share premium.

2.27 Forward contracts

Forward contracts are initially recognised at the fair value on the date the forward contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of forward contracts are recognised in the income statement within cost of sales, on the basis that is where the related expense is recognised, unless they are included in a hedging arrangement. Where the instruments have been traded to take advantage of currency movements and not directly linked to the settlement of purchase requirements the gain or loss is recognised separately in the statement of comprehensive income as other operating income/expense. Financial liabilities are derecognised when the liability is extinguished, that is when the contractual obligation is discharged, cancelled or expires.

3. Financial risk management

3.1 Financial risk factors

The Company's activities expose it to certain financial risks: market risk, credit risk and liquidity risk. The overall risk management programme focuses on the unpredictability of financial markets and seeks to minimise potential adverse effects on the Group's financial performance. Risk management is carried out by the Directors, who identify and evaluate financial risks in close co-operation with key staff, for further details see Note 22.

(a) Market risk

Market risk is the risk of loss that may arise from changes in market factors such as competitor pricing, interest rates, foreign exchange rates.

(b) Credit risk

Credit risk is the financial loss to the Group if a customer or counterparty to forward contracts derivatives fails to meet its contractual obligation. Credit risk arises from the Group's cash and cash equivalents and receivables balances. Credit Insurance is applied to all accounts over £5,000 with exception of proforma accounts and accounts agreed by the CEO and therefore credit risk is considered low.

Liquidity risk is the risk that the Group will not be able to meet its financial obligations as they fall due. This risk relates to the Group's prudent liquidity risk management and implies maintaining sufficient cash. The Directors monitor rolling forecasts of the Group's liquidity and cash and cash equivalents based on expected cash flow.

3.2 Capital risk management

The Group is funded by equity and loans. The components of shareholders' equity are:

(a) The share capital account arising on the issue of shares.

(b) The retained reserve or deficit reflecting comprehensive income to date.

Notes to the Group financial statements continued

for the Year Ended 31 March 2023

3. Financial risk management (continued)

The Group's objective when managing capital is to maintain adequate financial flexibility to preserve its ability to meet financial obligations, both current and long term. The capital structure of the Group is managed and adjusted to reflect changes in economic conditions. The Group funds its expenditures on commitments from existing cash and cash equivalent balances, primarily received from issuances of shareholders' equity. There are no externally imposed capital requirements. Financing decisions are made based on forecasts of the expected timing and level of capital and operating expenditure required to meet the Group's commitments and development plans. Quantitative data on what the Group manages as capital is included in the Statement of Changes in Equity and in Note 22 to the Group Financial Statements.

3.3 Fair value estimation

The carrying value less impairment provision of trade receivables and payables are assumed to approximate to their fair values because of the short-term nature of such assets and the effect of discounting liabilities is negligible.

4. Critical accounting estimates and judgements

The preparation of the Group financial statements require management to make judgements and estimates that affect the reported amounts of assets and liabilities at each Statement of Financial Position date and the reported amounts of revenue during the reporting periods. Actual results could differ from these estimates. Information about such judgements and estimations are contained in individual accounting policies. The key judgements and sources of estimation uncertainty that could cause an adjustment to be required to the carrying amount of asset or liabilities within the next accounting period are outlined below:

Accounting estimates

4.1 Goodwill impairment

The Group tests goodwill for impairment every year in accordance with the relevant accounting policies. The recoverable amounts of cash-generating units are determined by calculating value in use. These calculations require the use of estimates.

Goodwill relates to various acquisitions and amounts to £7,508,000 at 31 March 2023 (2022: £1,602,000). Management consider that the estimates used in the impairment calculation are set out in Note 12. There are no reasonably possible scenarios in which the goodwill would be impaired.

4.2 Useful economic lives of property, plant and equipment

Property, plant and equipment is depreciated over the useful lives of the assets. Useful lives are based on the management's estimates of the period that the assets will generate revenue, which are reviewed annually for continued appropriateness. The carrying values are tested for impairment when there is an indication that the value of the assets might be impaired. When carrying out impairment tests these would be based upon future cash flow forecasts and these forecasts would be based upon management judgement. Future events could cause the assumptions to change, therefore this could have an adverse effect on the future results of the Group.

The useful economic lives applied are set out in the accounting policies (Note 2.8) and are reviewed annually.

4.3 Valuation of acquired intangibles

IFRS 3 requires separately identifiable intangible assets to be recognised on acquisitions. The principal estimates used in valuing the acquired intangible assets are the future cash flows estimated to be generated from these assets, expected customer attrition, growth in revenues and the selection of appropriate discount rates to apply to the cash flows. The Directors' assessment of these estimates is based on up-to-date information and evidence available at the time of finalising the valuation.

Notes to the Group financial statements continued

for the Year Ended 31 March 2023

4. Critical accounting estimates and judgements (continued)

4.4 Right of use assets - discount rate

Management makes use of estimates in determining the discount rate to be applied to the IFRS 16 'Leases' right of use asset and liability. This estimate determines the carrying value of the assets and liabilities, and the resulting depreciation and interest charge that is incurred.

4.5 Share-based payments

Estimating fair value for share-based payment transactions requires determination of the most appropriate valuation model, which depends on the terms and conditions of the grant. This estimate also requires determination of the most appropriate inputs to the valuation model including the expected life of the share option or appreciation right, volatility and dividend yield and making assumptions about them. Options with both market and non-market conditions are most impacted by these estimates. The share options charge is subject to an assumption about the number of options that will vest as a result of the expected achievement of certain non-market conditions.

4.6 T-Juice disposal

As part of the Cuts Ice acquisition (as detailed in Notes 25 to these financial statements), Supreme acquired the intellectual property of the brand; T Juice out of administration. The purchase price allocation exercise valued the brand, at the time, at £1.2 million. In March 2023, seven months later, the brand was sold to a French distributor, LVP, for £4.0 million. During that seven-month period, Supreme had turned the brand around; the brand had become cash-generative with a more manageable product range, a leaner manufacturing process and a rationalised overhead base, all of which was reflected in the market value of the brand.

At the time of the disposal, Supreme signed two agreements with the buyer; an intellectual property sale-purchase agreement and an associated five-year professional services agreement. The 2 agreements were 'in connection' with one another (as legally drafted), had to be signed simultaneously and were payable upfront and non-refundable. Furthermore, the nature of the services referenced in the professional services agreement were not unlike services offered as standard to other customers without the need for a professional services agreement. Standing back from the 2 agreements, the Board concluded that the consideration assigned to the disposal of the IP should be recognised as the combined consideration paid upfront in respect of both agreements i.e. £4 million.

Accounting judgements

4.7 Inventory obsolescence

Management make use of judgement in determining whether certain inventory items are obsolete. Specifically this is done by looking at expiry dates, as well as sales data and forecasts as a proportion of current stock holding. Should these judgements be incorrect there could be a material difference in the recoverable value of inventory.

Notes to the Group financial statements continued

for the Year Ended 31 March 2023

5. Revenue and gross profit analysis

The Chief Operating Decision Maker ("CODM") has been identified as the Board of Directors. The Board reviews the Group's internal reporting in order to assess performance and allocate resources. The Board of Directors deem the Group to be one operating segment because no balance sheet analysis, cashflows, profit before tax or EBITDA (which are the KPI's for the business) are available by division or reviewed by the CODM. This has changed from prior year due to the changes to the Group following the significant acquisitions in the financial year.

However, the Gross profit before foreign exchange is reported and used to make decisions on a product group basis. The below table shows the results using standard foreign exchange rates that are used throughout the year. The foreign exchange adjustment shown before gross profit is to adjust back to the actual rates incurred.

	Batteries	Lighting	Vaping	Sports nutrition & wellness	Other consumer goods	Year Ended 31 March 2023
	£'000	£'000	£'000	£'000	£'000	£'000

Revenue	39,533	15,426	76,098	16,748	7,807	155,612
Cost of sales	(35,613)	(11,301)	(48,018)	(14,089)	(6,992)	(116,013)
Gross profit before foreign exchange	3,920	4,125	28,080	2,659	815	39,599

Foreign exchange						1,255
Gross Profit						40,854

Profit on disposal of Cuts Ice trademarks						2,787
Administration expenses						(28,192)
Operating profit						15,449

Adjusted earnings before tax, depreciation, amortisation and adjusted items						19,392
Depreciation						(2,200)
Amortisation						(915)
Adjusted items						(828)

Operating profit						15,449

Finance income						25
Finance costs						(1,037)
Profit before taxation						14,437

Income tax						(2,469)
Profit for the year						11,968

Notes to the Group financial statements continued

for the Year Ended 31 March 2023

5. Revenue and gross profit analysis (continued)

	Batteries	Lighting	Vaping	Sports nutrition & wellness	Other consumer goods	Year Ended 31 March 2022
	£'000	£'000	£'000	£'000	£'000	£'000

Revenue	34,865	27,022	43,594	15,893	9,415	130,789
Cost of sales	(31,184)	(18,066)	(24,092)	(12,351)	(8,219)	(93,912)
Gross profit before foreign exchange	3,681	8,956	19,502	3,542	1,196	36,877

Foreign exchange						1,640
Gross Profit						38,517

Administration expenses						(21,498)
Operating profit						17,019

Adjusted earnings before tax, depreciation, amortisation and adjusted items						21,055
Depreciation						(2,563)
Amortisation						(378)
Adjusted items						(1,095)

Operating profit						17,019

Finance income						-
Finance costs						(693)
Profit before taxation						16,326

Income tax						(2,579)
Profit for the year						13,747

Information about major customers

The Group has generated revenue from individual customers that accounted for greater than 10% of total revenue. The total revenue from each of these 3 customers (2022: 2 customers) was £24,938,000, £19,364,000, and £16,045,000 (2022: £21,111,000 and £18,385,000). These revenues related to all divisions.

Analysis of revenue by geographical destination

	Year Ended 31 March 2023	Year Ended 31 March 2022
	£'000	£'000
United Kingdom	140,713	115,938
Ireland	8,645	7,779
Netherlands	1,766	2,807
France	2,428	1,617
Rest of Europe	942	1,825
Rest of the World	1,118	823
	155,612	130,789

The above revenues are all generated from contracts with customers and are recognised at a point in time. All assets of the Group reside in the UK except for total net assets of £3,192,000 held in Europe.

Notes to the Group financial statements continued

for the Year Ended 31 March 2023

6. Expenses by nature

	Year Ended 31 March 2023	Year Ended 31 March 2022
	£'000	£'000
The profit is stated after charging expenses as follows:
Inventories recognised as an expense	103,129	81,813
Impairment of inventories	892	750
Impairment of trade receivables	63	30
Staff costs - Note 8	12,345	9,442
Adjusted items - Note 7	828	1,095
Establishment and general	2,142	1,473
Depreciation of property, plant and equipment	1,268	1,748
Depreciation of right of use assets	932	815
Amortisation of intangible assets	915	378
Auditor's remuneration for audit services	170	112
Auditor's remuneration for non-audit services	-	-
Other operating expenses	17,479	16,114
Total cost of sales and administrative expenses	140,163	113,770

7. Adjusted items

	Year Ended 31 March 2023	Year Ended 31 March 2022
	£'000	£'000
Covid-19-related cost	-	118
Fair value movements on forward contracts	1,119	(1,027)
Restructuring costs	-	208
Share based payments charge (note 24)	1,460	1,663
Acquisition costs	1,036	133
Profit on disposal of intangible fixed assets	(2,787)	-
	828	1,095

COVID-19 costs in the year ended 31 March 2022 relate to the entirely incremental agency staff that was hired during November and December 2021 following widespread absence within our manufacturing workforce due to COVID-related sickness and isolation. As these costs were deemed one-off in nature they were reported as Adjusted.

The Group typically holds 1 years' worth of USD-denominated purchases on open forward contracts. The charge in the year ended 31 March 2023 and the credit in the year ended 31 March 2022 reflect the movement in the fair value of these open forward contracts at the balance sheet date year-on-year. This charge or credit is reported each year but, due its volatile nature, is reported as Adjusted.

Restructuring costs in the year ended 31 March 2022 related to the restructuring of the sales functions within the Group, specifically around electrical wholesale and brand reps where customers have been redirected to the Supreme trade website for self-service ordering going forward. As these costs were deemed one-off in nature they were reported as Adjusted.

Notes to the Group financial statements continued

for the Year Ended 31 March 2023

7. Adjusted items (continued)

Acquisition costs relate to adviser fees in respect of the acquisitions undertaken and the subsequent financial and operational integration of these businesses into the core Supreme Group. £599,000 of the costs related to the redundancy costs in respect of the Cuts Ice Limited acquisition. These costs are notably volatile (linked to the volume and complexity of the acquisitions undertaken each year) and due to their size, have been reported as Adjusted.

Profit on disposal of the T Juice brand represents the difference between the cost of acquiring the brand (£1,231,000) and the proceeds on disposal (£4,018,000). The disposal of a brand was deemed to be one-off in nature and therefore reported as Adjusted.

8. Employees and Directors

	Year Ended 31 March 2023	Year Ended 31 March 2022
	No.	No.
Average number of employees (including Directors):
Management and administration	116	80
Warehouse	70	50
Sales	46	30
Manufacturing	124	105
	356	265

	Year Ended 31 March 2023	Year Ended 31 March 2022
	£'000	£'000
Aggregate remuneration of staff (including Directors):
Wages and salaries	10,670	8,339
Social security costs	1,193	765
Other pension costs	482	338
	12,345	9,442

Directors' remuneration

	Year Ended 31 March 2023	Year Ended 31 March 2022
	£'000	£'000
Directors' emoluments	600	635
Social security costs	83	88
Company contributions to defined contribution pension schemes	3	2
	686	725

The highest paid director received remuneration of £232,000 (2022: £300,000).

The value of the Company's contributions paid to a defined contribution pension scheme in respect of the highest paid director amounted to £1,000 (2022: £1,000).

During the year, retirement benefits were accruing to 2 directors (2022: 2) in respect of defined contribution pension schemes.

Notes to the Group financial statements continued

for the Year Ended 31 March 2023

9. Finance (income)/costs

	Year Ended 31 March 2023	Year Ended 31 March 2022
	£'000	£'000
Finance income
Bank interest receivable	(25)	-

Finance costs
Bank interest payable	828	153
Other interest payable	-	133
Amortisation of capitalised arrangement fees	55	289
Interest on lease liabilities	154	118
	1,037	693

10. Taxation

	Year Ended 31 March 2023	Year Ended 31 March 2022
Current tax	£'000	£'000
Current year - UK corporation tax	2,967	3,205
Adjustments to tax charge in respect of prior periods	-	(163)
Foreign tax on income	-	(7)
Total current tax	2,967	3,035

Deferred tax
Origination and reversal of temporary differences	(566)	(320)
Adjustments to tax charge in respect of prior periods	-	(173)
Adjustments to tax charge due to change in rates	68	37
Total deferred tax	(498)	(456)

Total tax expense	2,469	2,579

Factors affecting the charge

	Year Ended 31 March 2023	Year Ended 31 March 2022
	£'000	£'000
Profit before taxation	14,437	16,326
Tax at the UK corporation tax rate of 19% (2022: 19%)	2,743	3,102

Effects of expenses not deductible for tax purposes	123	317
Adjustments to tax charge due to change in rates	68	37
Adjustments to tax charge in respect of prior periods	-	(336)
Exercise of share options	(123)	-
Deferred tax on Share Based Payments	(118)	(471)
Enhanced Relief	(224)	(70)
Total tax expense	2,469	2,579

Notes to the Group financial statements continued

for the Year Ended 31 March 2023

10. Taxation (continued)

Factors that may affect future tax charges

In the Spring Budget 2021, the Government announced that from 1 April 2023 the corporation tax rate will increase to 25% rather than remaining at 19% as previously enacted. This new law was substantively enacted on 24 May 2021 and the impact of this rate change has been considered when recognising deferred tax in these financial statements. Where the asset or liability is expected to unwind after 1 April 2023 the deferred tax has been recognised at 25% in these financial statements. In the Autumn Statement in November 2022, the government confirmed the increase in corporation tax rate to 25% from April 2023 will go ahead.

11. Earnings per share

Basic earnings per share is calculated by dividing the net income for the year attributable to ordinary equity holders after tax by the weighted average number of ordinary shares outstanding during the year.

Diluted earnings per share is calculated with reference to the weighted average number of shares adjusted for the impact of dilutive instruments in issue. For the purposes of this calculation an estimate has been made for the share price in order to calculate the number of dilutive share options.

The basic and diluted calculations are based on the following:

Statutory EPS

	Year Ended 31 March 2023	Year Ended 31 March 2022
	£'000	£'000
Profit for the year after tax	11,968	13,747

	No.	No.
Weighted average number of shares for the purposes of basic earnings per share	116,731,311	116,605,892
Weighted average dilutive effect of conditional share awards	6,720,523	4,474,425
Weighted average number of shares for the purposes of diluted earnings per share	123,451,834	121,080,317

	Pence	Pence
Basic earnings per share	10.3	11.8
Diluted earnings per share	9.7	11.4

Notes to the Group financial statements continued

for the Year Ended 31 March 2023

11. Earnings per share (continued)

Adjusted EPS

The calculation of adjusted earnings per share is based on the after tax adjusted operating profit after adding back certain costs as detailed in the table below. Adjusted earnings per share figures are given to exclude the effects of depreciation, amortisation and adjusted items, all net of taxation, and are considered to show the underlying performance of the Group.

	Year Ended 31 March 2023	Year Ended 31 March 2022
	£'000	£'000
Adjusted earnings (see below)	13,790	14,976

	No.	No.
Weighted average number of shares for the purposes of basic earnings per share	116,731,311	116,605,892
Weighted average dilutive effect of conditional share awards	6,720,523	4,474,425
Weighted average number of shares for the purposes of diluted earnings per share	123,451,834	121,080,317

	Pence	Pence
Adjusted basic earnings per share	11.8	12.8
Adjusted diluted earnings per share	11.2	12.4

The calculation of basic adjusted earnings per share is based on the following data:

	Year Ended 31 March 2023	Year Ended 31 March 2022
	£'000	£'000
Profit for the year attributable to equity shareholders	11,968	13,747
Add back/(deduct):
Amortisation of acquisition related intangible assets	874	196
Adjusted items	828	1,095
Tax effect of the above	120	(62)
Adjusted earnings	13,790	14,976

Notes to the Group financial statements continued

for the Year Ended 31 March 2023

12. Goodwill and other intangible assets

	Domain name £'000	Trademarks £'000	Customer relationships £'000	Trade name £'000	Know how £'000	Computer software £'000	Goodwill £'000	Total £'000
Cost
At 1 April 2021	249	65	760	221	-	-	1,602	2,897
Additions	-	1,436	-	-	-	18	-	1,454
At 31 March 2022	249	1,501	760	221	-	18	1,602	4,351

Additions	-	-	-	-	-	23	-	23
On acquisition	62	43	3,043	4,384	262	-	5,906	13,700
Disposals	-	-	-	(1,231)	-	-	-	(1,231)
At 31 March 2023	311	1,544	3,803	3,374	262	41	7,508	16,843

Accumulated amortisation
At 1 April 2021	50	16	159	44	-	-	-	269
Amortisation charged in the year	25	150	152	44	-	7	-	378
At 31 March 2022	75	166	311	88	-	7	-	647

Amortisation charged in the year	25	150	359	359	6	16	-	915
At 31 March 2023	100	316	670	447	6	23	-	1,562

Carrying amount
At 1 April 2021	199	49	601	177	-	-	1,602	2,628
At 31 March 2022	174	1,335	449	133	-	11	1,602	3,704
At 31 March 2023	211	1,228	3,133	2,927	256	18	7,508	15,281

The amortisation charge for the year has been included in Administrative expenses in the Statement of Comprehensive Income.

Notes to the Group financial statements continued

for the Year Ended 31 March 2023

12. Goodwill and other intangible assets (continued)

Goodwill arises on acquisitions where the fair value of the consideration given for the business exceeds the fair value of the assets acquired and liabilities assumed.

Following acquisition of a business, the directors identify the individual Cash Generating Units (CGUs) acquired and, where possible, allocate the underlying assets acquired and liabilities assumed to each of those CGUs. The carrying value of goodwill has arisen following the acquisition of subsidiary entities, where the trade and assets have subsequently been hived up into this company, and the related investment balance transferred to goodwill. The carrying value of goodwill is allocated to the following cash generating units:

	As at 31 March 2023	As at 31 March 2022
	£'000	£'000
Supreme	3,364	1,602
Liberty Flights	4,144	-
	7,508	1,602

The above CGU's have changed from prior year due to the changes to the Group following the significant acquisitions in the financial year.

Goodwill arising in the year ended 31 March 2023 related to the acquisition of Liberty Flights Limited and Liberty Flights Holdings Limited and Superdragon (note 25). Goodwill arising in the year ended 31 March 2021 related to the acquisition of GT Divisions Limited. Goodwill arising in the year ended 31 March 2020 related to the acquisition of Provider Distribution Limited, Holding Esser Affairs B.V. and its subsidiary AGP Trading B.V. and Monocore Limited. Goodwill arising before 1 April 2019 related to the acquisition of Powerquick, Vape Importers and Sub Ohm that was hived up into Supreme Imports Ltd. No Goodwill arose on the acquisition of Vendek Limited.

The key assumptions for the value in use calculations are:

· cash flows before income taxes are based on approved budgets and prior experience and management projections for the next 3 years;

· a long term growth rate of 2.0% (2022: 2.0%) for the period beyond which detailed budgets and forecasts do not exist; based on external sources of macroeconomic projections for the geographies in which the entity operates; and

· a post tax discount rate of 10.4% (2022: 14.4%) based upon risk free rate for government bonds adjusted for a risk premium to reflect increased risk of investing in equities and investing in the Group's specific sector and regions.

Impairment testing of goodwill is performed at least annually by reference to value in use calculations which management consider to be in line with the requirements of IAS 36. These calculations show no reasonably possible scenario in which any of the goodwill balances could be impaired as at 31 March 2023 or 31 March 2022. There were no charges for impairment of goodwill in 2023 (2022: nil).

Notes to the Group financial statements continued

for the Year Ended 31 March 2023

13. Property, plant and equipment

	Buildings £'000	Plant and machinery £'000	Fixtures and fittings £'000	Motor vehicles £'000	Computer equipment £'000	Assets under construction £'000	Total £'000
Cost or valuation
At 1 April 2021	-	5,316	770	51	100	-	6,237
Additions	-	802	201	57	236	-	1,296
On acquisition	378	21	22	179	-	-	600
Disposals	(378)	-	-	-	-	-	(378)
At 31 March 2022	-	6,139	993	287	336	-	7,755

Additions	57	724	66	111	340	686	1,984
On acquisition	1,492	423	33	7	11	-	1,966
Disposals	-	-	-	(28)	-	-	(28)
At 31 March 2023	1,549	7,286	1,092	377	687	686	11,677

Depreciation and impairment
At 1 April 2021	-	2,771	641	27	11	-	3,450
Depreciation charged in the year	-	1,411	181	64	92	-	1,748
At 31 March 2022	-	4,182	822	91	103	-	5,198

Depreciation charged in the year	-	949	63	51	205	-	1,268
Eliminated on disposal	-	-	-	(27)	-	-	(27)
At 31 March 2023	-	5,131	885	115	308	-	6,439

Carrying amount
At 1 April 2021	-	2,545	129	24	89	-	2,787
At 31 March 2022	-	1,957	171	196	233	-	2,557
At 31 March 2023	1,549	2,155	207	262	379	686	5,238

The depreciation charge for the year has been included in Administrative expenses in the Statement of Comprehensive Income.

Of the additions in the financial year £1,254,000 was paid during the year.

Notes to the Group financial statements continued

for the Year Ended 31 March 2023

14. Investments

	As at 31 March 2023	As at 31 March 2022
	£'000	£'000
Balance at the beginning of the year	7	7
Balance at the end of the year	7	7

The balance of £7,000 relates to shares held in private entities, by the acquired subsidiary, who are unlisted. IFRS 9 require these to be measured at fair value, however due to the nature of the investment, the cost has been deemed the fair value of the investment.

The Company owns 20% of the share capital of Elena Dolce Limited, with a registered office of 111 Deansgate, Manchester, M3 2BQ. This was written off in the prior year.

At 31 March 2023, the Company directly owned 100% of the ordinary share capital of the following subsidiaries, which are incorporated in England and Wales unless stated:

Subsidiary	Registered address	Principal activity
Supreme Imports Limited	4 Beacon Road, Ashburton Park, Trafford Park, Manchester M17 1AF	Distribution of consumer goods
Provider Distribution Limited	Unit 1 Rosewood Park, St James Road, Blackburn, Lancashire BB1 8ET	Distribution of consumer goods

At 31 March 2022, the Company indirectly owned 100% of the ordinary share capital of the following subsidiaries, which are incorporated in England and Wales unless stated:

Subsidiary	Registered address	Principal activity
VN Labs Limited	4 Beacon Road, Ashburton Park, Trafford Park, Manchester, M17 1AF	Distribution of consumer goods
Battery Force Limited		Dormant
Powerquick Limited		Holding company
Supreme 88 Limited		Holding company
Supreme Nominees Limited		Holding of shares as nominee
Holding Esser Affairs B.V.	Vanadiumweg 13, 3812 PX, Armersfoort, Netherlands	Holding company
AGP Trading B.V.	Vanadiumweg 13, 3812 PX, Armersfoort, Netherlands	Distribution of consumer goods
Vendek Limited	Unit C5, South City Business Park, Whitestown Way, Tallaght, Dublin 24, D24 A993	Distribution of consumer goods
Liberty Flights Holdings Limited	Unit 9 Arkwright Court, Commercial Road, Darwen, Lancashire, BB3 0FG	Holding company
Liberty Flights Limited		Distribution of consumer goods

The Directors believe that the carrying value of the investments is supported by their underlying net assets.

Notes to the Group financial statements continued

for the Year Ended 31 March 2023

15. Deferred tax

Deferred tax consists of the following temporary differences

	As at 31 March 2023	As at 31 March 2022
	£'000	£'000
Share based payments	1,016	1,312
Deferred tax asset	1,016	1,312

Excess of depreciation over taxable allowances	(550)	(53)
Short term temporary differences	339	(103)
Tax losses carried forward	(104)	-
Acquired intangible assets	(1,490)	-
Deferred tax liability	(1,805)	(156)
Net deferred tax (liability)/asset	(789)	1,156

Movement in deferred tax in the year

	As at 31 March 2023	As at 31 March 2022
	£'000	£'000
Balance at the beginning of the year	1,156	(141)
Credited to profit or loss	498	456
(Debited)/credited to reserves	(608)	841
Arising on business combination	(1,849)	-
Other	14	-
Balance at the end of the year	(789)	1,156

The Directors consider that the deferred tax assets in respect of temporary differences are recoverable based on the forecast future taxable profits of the Group.

16. Inventories

	As at 31 March 2023	As at 31 March 2022
	£'000	£'000
Goods for resale	21,080	20,457
Raw materials	4,526	5,441
	25,606	25,898

The Directors believe that the replacement value of inventories would not be materially different than book value.

Inventories at 31 March 2023 are stated after provisions for impairment of £1,492,000 (2022: £600,000).

Notes to the Group financial statements continued

for the Year Ended 31 March 2023

17. Trade and other receivables

	As at 31 March 2023	As at 31 March 2022
	£'000	£'000
Trade receivables	18,566	17,848
Other receivables	1,507	346
Prepayments	826	841
	20,899	19,035

The Directors believe that the carrying value of trade and other receivables represents their fair value. In determining the recoverability of trade receivables, the Group considers any change in the credit quality of the receivable from the date credit was granted up to the reporting date.

The movement in provisions for impairment are shown below:

	Year Ended 31 March 2023	Year Ended 31 March 2022
	£'000	£'000
Balance at the beginning of the year	32	37
Charged to the statement of comprehensive income	63	30
Arising on acquisition	111	-
Utilisation of provision	(17)	(35)
Balance at the end of the year	189	32

Trade receivables disclosed above include amounts (see below for aged analysis) which are past due at the reporting date but against which the Group has not recognised an allowance for doubtful receivables because there has not been a significant change in credit quality and the amounts are still considered recoverable.

Ageing of receivables

	As at 31 March 2023	As at 31 March 2022
	£'000	£'000
Current	11,936	12,177
31 - 60 days	5,253	4,390
61 - 90 days	1,492	1,254
90 days +	74	59
Less provisions for impairment	(189)	(32)
	18,566	17,848

In determining the recoverability of a trade receivable the Group considers any change in the credit quality of the trade receivable from the date credit was initially granted up to the reporting date. The concentration of credit risk is limited due to the customer base being large and unrelated. Credit insurance is also in place.

Details on the Group's credit risk management policies are shown in Note 22. The Group does not hold any collateral as security for its trade and other receivables.

Notes to the Group financial statements continued

for the Year Ended 31 March 2023

18. Cash and cash equivalents

As at

31 March 2023

As at

31 March 2022

£'000

Cash at bank

7,536

3,926

19. Trade and other payables

	As at 31 March 2023	As at 31 March 2022
	£'000	£'000
Trade payables	8,697	8,149
Accruals	5,651	6,302
Deferred income	259	-
Other creditors	3,415	-
Other tax and social security	3,951	2,843
Deferred consideration	1,942	-
Contingent consideration	2,200	-
Directors loan account	2	2
	26,117	17,296

Trade payables principally consist of amounts outstanding for trade purchases and ongoing costs. They are non-interest bearing and are normally settled on 30 to 60 day terms.

The Directors consider that the carrying value of trade and other payables approximates their fair value. Trade and other payables are denominated in Sterling, Euros and US Dollars. Supreme PLC has financial risk management policies in place to ensure that all payables are paid within the credit timeframe and no interest has been charged by any suppliers as a result of late payment of invoices during the period.

20. Borrowings

	As at 31 March 2023	As at 31 March 2022
	£'000	£'000
Current
Bank loans	4,307	3,984
Amounts owed to related parties	-	1,779
IFRS 16 lease liability (Note 21)	719	902
	5,026	6,665

Non-current
IFRS 16 lease liability (Note 21)	14,293	1,294
	14,293	1,294

Total borrowings	19,319	7,959

Notes to the Group financial statements continued

for the Year Ended 31 March 2023

20. Borrowings (continued)

The earliest that the lenders of the above borrowings require repayment is as follows:

	As at 31 March 2023	As at 31 March 2022
	£'000	£'000
In less than one year	5,026	6,665
Between two and five years	6,980	1,294
In more than five years	7,313	-
	19,319	7,959

These amounts when presented gross on an undiscounted basis are as follows:

	As at 31 March 2023	As at 31 March 2022
	£'000	£'000
In less than one year	5,499	6,751
Between two and five years	7,699	1,388
In more than five years	13,065	-
	26,263	8,139

The Group is funded by revolving credit facility ("RCF") of £25m provided by HSBC that is secured by way of a fixed and floating charge over all assets. Interest is charged at a margin of 2.3%-2.8% over SONIA for all drawn amounts and 35% of the margin for undrawn amounts. The facility is for 3 years and expires 31 March 2025. There are 2 principal covenants attached to the RCF and these are tested quarterly.

Current bank facilities include an invoice discounting facility of £8.5m, which is secured by an assignment of, and fixed charge over the trade debtors of Supreme Imports Limited. The facility was not drawn down at year end.

Furthermore, the Group has access to a supply chain facility (also provided by HSBC) of $0.5m which is secured by fixed and floating charges over all assets of the Group. This facility is denominated in US Dollars. At the balance sheet date the facility is undrawn (2022: undrawn).

Therefore undrawn but committed facilities at 31 March 2023 were £20.7m for the RCF (2022: £25m), £8.5m for the invoice discounting facility (2022: £8.4m) and $0.5m for the supply chain facility (2022: $0.5m).

The supply chain facility is utilised to provide short term cash flow to settle liabilities arising out of purchases made in the normal course of business. The amount advanced takes into consideration the cash requirements of the Group and the working capital cycle.

Notes to the Group financial statements continued

for the Year Ended 31 March 2023

21. Leases

Amounts recognised in the Statement of Financial Position

The balance sheet shows the following amounts relating to leases:

Right-of-use assets	£'000

At 1 April 2021	1,476
Additions	1,455
Depreciation charge for the year	(815)
At 31 March 2022	2,116
Additions	12,656
Lease modification	1,737
Depreciation charge for the year	(932)
At 31 March 2023	15,577

The net book value of the right of use assets is made up as follows:

	As at 31 March 2023	As at 31 March 2022
	£'000	£'000
Buildings	15,576	2,108
Cars	1	8
	15,577	2,116

Notes to the Group financial statements continued

for the Year Ended 31 March 2023

21. Leases (continued)

Lease liabilities	As at 31 March 2023	As at 31 March 2022
	£'000	£'000
Maturity analysis - contractual undiscounted cash flows
Less than one year	1,192	988
More than one year, less than two years	2,181	514
More than two years, less than three years	2,121	467
More than three years, less than four years	1,714	407
More than four years, less than five years	1,683	-
More than five years	13,065	-
Total undiscounted lease liabilities at year end	21,956	2,376
Finance costs	(6,944)	(180)
Total discounted lease liabilities at year end	15,012	2,196

Lease liabilities included in the statement of financial position
Current	719	902
Non-current	14,293	1,294
	15,012	2,196

Provisions
Dilapidations provision related to right-of-use assets
At 1 April	-	-
Additions	774	-
Unwind of discounting	1	-
At 31 March	775	-

Amounts recognised in the Consolidated Statement of Comprehensive Income

The Consolidated Statement of Comprehensive Income shows the following amounts relating to leases:

	Year Ended 31 March 2023	Year Ended 31 March 2022
	£'000	£'000
Depreciation charge - Buildings	925	794
Depreciation charge - Cars	7	21
	932	815

Interest expense (within finance expense)	154	118

The above leases relate to buildings and cars.

There are no restrictions or covenants imposed by leases and there have been no sale and leaseback transactions.

Any expense for short-term and low-value leases is not material and has not been presented.

22. Financial instruments

The Group is exposed to the risks that arise from its financial instruments. The policies for managing those risks and the methods to measure them are described in Notes 2 and 3. Further quantitative information in respect of these risks is presented below and throughout these Group financial statements.

22.1 Capital risk management

Details of the Group's capital are shown in Note 23, as well as in the Statement of Changes in Equity.

22.2. Market risk

Competitive pressures remain a principal risk for the Group. The risk is managed through focus on quality of product and service levels, coupled with continuous development of new products to offer uniqueness to the customer. Furthermore, the Group's focus on offering its customers a branded product range provides some protection to its competitive position in the market. Stock obsolescence risk is managed through closely monitoring slow moving lines and prompt action to manage such lines through the various distribution channels available to the Group.

In addition, the Group's operations expose it to a variety of financial risks that include price risk, credit risk, liquidity risk, foreign currency risk and interest rate cash flow risk. The Group has in place a risk management programme that seeks to limit the adverse effects on the financial performance of the Group by regularly monitoring the financial risks referred to above.

Given the size of the Group, the Directors have not delegated the responsibility of monitoring financial risk management to a sub-committee of the board. The policies set by the Board are implemented by the Group's finance department.

22.3. Credit risk

The Group's sales are primarily made with credit terms of between 0 and 30 days, exposing the Group to the risk of non-payment by customers. The Group has implemented policies that require appropriate credit checks on potential customers before sales are made. The amount of exposure to any individual counterparty is subject to a limit, which is reassessed regularly by the board. In addition, the Group maintains a suitable level of credit insurance against its debtor book. The maximum exposure to credit risk is £5,000 per individual customer that is covered by the policy, being the insurance excess.

The Group applies the IFRS 9 simplified approach to measuring expected credit losses using a lifetime expected credit loss provision for trade receivables. Expected losses are based on the Group's historical credit losses, adjusted for current and forward-looking information on macroeconomic factors affecting the Group's customers. The Group's B2B historic credit losses have been minimal on the back of strong credit control, in addition to the insurance cover in place. This results in an immaterial expected credit loss being provided for.

An analysis of past due but not impaired trade receivables is given in Note 17.

Notes to the Group financial statements continued

for the Year Ended 31 March 2023

22. Financial instruments (continued)

22.4. Liquidity risk management

The Group is funded by external banking facilities provided by HSBC. Within these facilities, the Group actively maintains a mixture of long-term and short-term debt finance that is designed to ensure the Group has sufficient available funds for operations and planned expansions. This is monitored on a monthly basis, including re-forecasts of the borrowings required.

22.5. Foreign currency risk management

The Group's activities expose it to the financial risks of changes in foreign currency exchange rates. The Group's exposure to foreign currency risk is partially hedged by virtue of invoicing a proportion of its turnover in US Dollars. When necessary, the Group uses foreign exchange forward contracts to further mitigate this exposure.

The following is a note of the assets and liabilities denominated at each period end in US dollars:

	As at 31 March 2023	As at 31 March 2022
	£'000	£'000
Trade receivables	-	1,498
Cash	58	188
Trade payables	1,154	820
	1,212	2,506

The effect of a 20 percent strengthening of Pound Sterling at 31 March 2023 on the foreign denominated financial instruments carried at that date would, all variables held constant, have resulted in a decrease to total comprehensive income for the year and a decrease to net assets of £202,000, (2022: £418,000). A 20 percent weakening of the exchange rate on the same basis, would have resulted in an increase to total comprehensive income and an increase to net assets of £303,000 (2022: £627,000).

The following is a note of the assets and liabilities denominated at each period end in Euros:

	As at 31 March 2023	As at 31 March 2022
	£'000	£'000
Trade receivables	200	51
Cash	453	27
Trade payables	(364)	(261)
	289	(183)

The effect of a 20 percent strengthening of Pound Sterling at 31 March 2023 on the foreign denominated financial instruments carried at that date would, all variables held constant, have resulted in an increase to total comprehensive income for the year and a decrease to net assets of £48,000 (2022: increase of £31,000). A 20 percent weakening of the exchange rate on the same basis, would have resulted in a decrease to total comprehensive income and an increase in net assets of £73,000 (2022: decrease of £46,000).

Notes to the Group financial statements continued

for the Year Ended 31 March 2023

22. Financial instruments (continued)

Forward contracts

The Group mitigates the exchange rate risk for certain foreign currency creditors by entering into forward currency contracts. The Group's forex policy is to purchase forward contracts to mitigate changes in spot rates, based on the timing of purchases to be made. Management forecast the timing of purchases and make assumptions relating to the exchange rate at which the Group costs its products and take out forward contracts to mitigate fluctuations to an acceptable level. At 31 March 2023, the outstanding contracts mature between 1 and 10 months of the year end, (2022: 2 and 10 months). At 31 March 2023 the Group was committed to buy $32,500,000 (2022: $18,700,000) in the next financial year.

The forward currency contracts are measured at fair value using the relevant exchange rates for GBP:USD and GBP:EUR. The fair value of the contracts at 31 March 2023 is a liability of £652,000 (2022: asset of £467,000). During the year ended 31 March 2023, a loss of £1,119,000 (2022: profit of £1,027,000) was recognised Adjusted items for changes in the fair value of the forward foreign currency contracts.

Forward currency contracts are valued using level 2 inputs. The valuations are calculated using the year end exchange rates for the relevant currencies which are observable quoted values at the year-end dates. Valuations are determined using the hypothetical derivative method which values the contracts based on the changes in the future cashflows based on the change in value of the underlying derivative.

22.6. Interest rate cash flow risk

The Group's interest-bearing liabilities relate to its variable rate banking facilities. The Group has a policy of keeping the rates associated with funding under review in order to react to any adverse changes in the marketplace that would impact on the interest rates in place. The effect of a 1% increase in interest rates would have resulted in a decrease in net assets of £141,000 (2022: £69,000).

22.7. Price risk

The Group's profitability is affected by price fluctuations in the sourcing of its products. The Group continually monitors the price and availability of materials but the costs of managing the exposure to price risk exceed any potential benefits given the extensive range of products and suppliers. The Directors will revisit the appropriateness of this policy should the Group's operations change in size or nature.

22.8. Maturity of financial assets and liabilities

All of the Group's non-derivative financial liabilities and its financial assets at the reporting date are either payable or receivable within one year, except for borrowings as disclosed in Note 20.

Notes to the Group financial statements continued

for the Year Ended 31 March 2023

22. Financial instruments (continued)

22.9 Summary of financial assets and liabilities by category

The carrying amount of financial assets and liabilities recognised may also be categorised as follows:

	As at 31 March 2023	As at 31 March 2022
	£'000	£'000
Financial assets
Financial assets measured at amortised cost
Trade and other receivables	20,073	18,194
Cash and cash equivalents	7,536	3,926
	27,609	22,120
Financial liabilities
Financial liabilities measured at amortised cost
Non-current:
Borrowings	(14,293)	(1,294)
Current:
Borrowings	(5,026)	(6,665)
Trade and other payables	(8,697)	(8,149)
Directors loan account	(2)	(2)
Deferred consideration	(1,942)	-
Contingent consideration	(2,200)	-
Other creditors	(3,415)	-
Accruals	(5,651)	(6,302)
	(41,226)	(22,412)

Financial assets / (liabilities) measured at fair value through profit and loss
Forward contracts	(652)	467
	(652)	467

Net financial (liabilities) / assets	(14,269)	175

Notes to the Group financial statements continued

for the Year Ended 31 March 2023

23. Share capital and reserves

Share capital and share premium

Equity instruments issued by the Company are recognised at the proceeds received, net of direct issue costs. The excess of proceeds of a share issue over the nominal value is presented within share premium.

Number of shares authorised and in issue

	Ordinary £0.10
	No.	£
At 31 March 2022	116,627,074	11,662,707
Issued	688,968	68,897
At 31 March 2023	117,316,042	11,731,604

On 2 February 2023, 561,874 new Ordinary £0.10 shares were issued at a subscription price of £0.38, generating share premium of £159,404.

On 6 March 2023, 63,547 new Ordinary £0.10 shares were issued at a subscription price of £0.38, generating share premium of £18,028.

On 14 March 2023, 63,547 new Ordinary £0.10 shares were issued at a subscription price of £0.38, generating share premium of £18,028.

Dividends

Dividends of £5,365,000 (2022: £2,566,000) were declared in the year. This amounted to £0.046 per share (2022: £0.022).

Merger reserve

The merger reserve arose on a past business combination of entities that were under common control. The merger reserve is the difference between the cost of investment and the nominal value of the share capital acquired.

Share-based payments reserve

The share-based payments reserve represents the cumulative impact of the share-based payments charge.

Retained earnings

Retained earnings includes all current and prior period retained profits and losses, including foreign currency translation differences arising from the translation of financial statements of the Company's foreign entities.

All transactions with owners of the parent are recorded separately within equity.

Notes to the Group financial statements continued

for the Year Ended 31 March 2023

24. Share based payments

The Group operates a number of share incentive arrangements as set out below.

The Supreme plc Enterprise Management Incentive Scheme ("the EMI Scheme")

On 14 September 2018, the Group implemented an Enterprise Management Incentive Scheme. This was granted to employees to acquire shares in the Company for a number of ordinary shares of 10p each at the exercise price at the option of the employee. The exercise of these options was originally subject to the occurrence of a relevant event (a disposal or a listing) in accordance with the EMI Scheme rules, but this condition was satisfied by the 2021 listing of the Company. These options will expire 10 years from grant date. A second scheme was implemented alongside the EMI scheme ('2018 unapproved scheme') for one employee who was eligible for more options that the EMI scheme rules allowed for. All conditions of this scheme were the same as the EMI Scheme.

These options were fairly valued upon a valuation of the entity that had been performed by an independent expert.

2018 EMI scheme	Weighted average exercise price 2023 £	2023 No.	Weighted average exercise price 2022 £	2022 No.
At the start of the year	£0.38	1,148,850	£0.38	1,281,028
Lapsed	£0.38	(30,504)	£0.38	(5,084)
Granted	-	-	-	-
Exercised	£0.38	(495,621)	£0.38	(127,094)
At the end of the year	£0.38	622,725	£0.38	1,148,850

The profit and loss expense that has been recognised in the current year in respect of these awards is £nil (2022: £nil).

2018 unapproved scheme	Weighted average exercise price 2023 £	2023 No.	Weighted average exercise price 2022 £	2022 No.
At the start of the year	£0.38	386,694	£0.38	386,694
Lapsed	-	-	-	-
Granted	-	-	-	-
Exercised	£0.38	(193,347)	-	-
At the end of the year	£0.38	193,347	£0.38	386,694

The profit and loss expense that has been recognised in the current year in respect of these awards is £94,000 (2022: £300,000).

The Supreme plc Sharesave Scheme 2021 ("the SAYE Scheme")

The Company established the SAYE Scheme on 26 January 2021. The SAYE Scheme is open to all employees who have achieved the qualifying length of service at the proposed date of grant (initially set at 3 months). Under the SAYE Scheme, an individual who wishes to accept an invitation to apply form options to be granted to him or her must take out a 3 or 5 year savings contract with an approved savings body selected by the Company. The

Notes to the Group financial statements continued

for the Year Ended 31 March 2023

individual makes a fixed monthly contribution over the life of the savings contract and on maturity receives a tax-free bonus. The monthly contribution can be a minimum of £10 and a maximum of £500.

24. Share based payments (continued)

The price at which options may be exercised will be set by the Directors at the date of grant and may be at a discount of up to a maximum of 20 per cent. against the market value at the date of grant of the Shares over which they are granted. The Option will generally be exercisable by the holder within six-month period after the bonus becomes payable on his or her relevant savings contract.

All employees of the Group (including executive directors) at 3 March 2021 were invited to participate in the SAYE Scheme. Employees were invited to subscribe for options over the Company's ordinary shares of 10p each with an exercise price of 152p, which represents a 20% discount to the closing middle market price of 190p per Share ("Options") on 2 March 2021, being the trading day before the invitation for employees to participate was made. Other than in the case of a takeover or demerger or similar event, an option will generally be exercisable by the holder in relation to the SAYE Scheme within the 6-month period after the bonus becomes payable on his or her relevant savings contract. Any option not so exercised will lapse. There are no conditions of exercise in relation to options granted under the SAYE Scheme.

2021 SAYE scheme	Weighted average exercise price 2023 £	2023 No.	Weighted average exercise price 2022 £	2022 No.
At the start of the year	£1.52	354,078	£1.52	438,620
Lapsed	£1.52	(158,911)	£1.52	(84,542)
Granted	-	-	-	-
Exercised	-	-	-	-
At the end of the year	£1.52	195,167	£1.52	354,078

The Supreme plc Company Share Option Plan 2021 ("the CSOP Scheme")

The Company established the CSOP Scheme on 26 January 2021. Grants under the CSOP Scheme may be made by the Company as subscription Options or, with the consent of the Remuneration Committee, by an existing shareholder over shares already issued.

Under the CSOP Scheme certain eligible employees have been granted options to subscribe for ordinary shares in the Company of 10p each with an exercise price of 174 pence per ordinary share equal to the closing middle market price on 15 February 2021. The options were granted on 16 February 2021 and may be exercisable by the holder at any time between the third and tenth anniversaries of the date of the grant. Upon exercise, the relevant Shares will be allotted. A number of employees have been granted additional options on the same basis under the Unapproved Scheme detailed below to the extent that the total number of options granted to them exceeded the maximum number permitted to be granted under the CSOP Scheme by HMRC rules.

23 employees were granted options under the CSOP over a total of 206,886 shares and 4 employees have been granted options under the Unapproved Scheme over a total of 94,825 Shares, being in aggregate 301,711 shares. By 31 March 2023, a total of 66,089 options had lapsed and 235,622 remained under option.

Notes to the Group financial statements continued

for the Year Ended 31 March 2023

24. Share based payments (continued)

2021 CSOP	Weighted average exercise price 2023 £	2023 No.	Weighted average exercise price 2022 £	2022 No.
At the start of the year	£1.74	201,140	£1.74	206,886
Lapsed	£1.74	(20,114)	£1.74	(5,746)
Granted	-	-	-	-
Exercised	-	-	-	-
At the end of the year	£1.74	181,026	£1.74	201,140


2021 unapproved scheme	Weighted average exercise price 2023 £	2023 No.	Weighted average exercise price 2022 £	2022 No.
At the start of the year	£1.74	94,825	£1.74	94,825
Lapsed	£1.74	(40,229)	-	-
Granted	-	-	-	-
Exercised	-	-	-	-
At the end of the year	£1.74	54,596	£1.74	94,825

The profit and loss expense that has been recognised in the current year in respect of these awards is £57,000 (2022: £57,000).

The Supreme plc Unapproved Share Option Scheme 2021 ("the Unapproved Scheme")

The Company established the Unapproved Scheme on 26 January 2021. Grants under the CSOP Scheme may be made by the Company as subscription Options or, with the consent of the Remuneration Committee, by an existing shareholder over shares already issued.

As described in the Directors' Remuneration Report, on 9 March 2021 the Company awarded the following options to the executive directors under the Unapproved Scheme.

Options to subscribe for a total of 5,825,000 Shares at nominal value were granted to the CEO in two equal tranches. Each tranche of options will be subject to a performance condition which must be wholly satisfied for the relevant option to be exercisable. The performance condition for the first tranche of options is that total shareholder return per Share ("TSR") from Admission until the third anniversary of Admission is at least 100 per cent. of the placing price of 134 pence as at Admission (the "Placing Price"). The performance condition for the second tranche of options is that the TSR from Admission until the fifth anniversary of Admission is at least 200 per cent. of the Placing Price.

Options to subscribe for up to 111,940 Shares at nominal value were granted to the CFO in the year ended 31 March 2022. The options are subject to a performance condition requiring an average annual TSR of 7.5 per cent. to become exercisable in part and an annual average TSR of 10 per cent. to become fully exercisable, in each case measured over a period of 3 years from Admission as against the Placing Price.

Notes to the Group financial statements continued

for the Year Ended 31 March 2023

24. Share based payments (continued)

Options to subscribe for a further 174,650 shares at nominal value were granted to the CFO during the year ended 31 March 2023. These options are subject to performance conditions. 50% of the options require an average annual TSR of 7.5% to become exercisable in part and an annual average of TSR of 10% to become fully exercisable measured over a 3-year period. The remaining 50% of options are linked to an EPS performance target where a threshold of 33.7p by the end of a 3-year period is required in order for the options to become exercisable and 41.1p in order for the options to be fully exercisable.

2021 3-year CEO award	Weighted average exercise price 2023 £	2023 No.	Weighted average exercise price 2022 £	2022 No.
At the start of the year	£0.00	2,912,500	£0.00	2,912,500
Lapsed	-	-	-	-
Granted	-	-	-	-
Exercised	-	-	-	-
At the end of the year	£0.00	2,912,500	£0.00	2,912,500


2021 5-year CEO award	Weighted average exercise price 2023 £	2023 No.	Weighted average exercise price 2022 £	2022 No.
At the start of the year	£0.00	2,912,500	£0.00	2,912,500
Lapsed	-	-	-	-
Granted	-	-	-	-
Exercised	-	-	-	-
At the end of the year	£0.00	2,912,500	£0.00	2,912,500


2021 CFO award	Weighted average exercise price 2023 £	2023 No.	Weighted average exercise price 2022 £	2022 No.
At the start of the year	£0.00	111,940	£0.00	111,940
Lapsed	-	-	-	-
Granted	-	-	-	-
Exercised	-	-	-	-
At the end of the year	£0.00	111,940	£0.00	111,940

Notes to the Group financial statements continued

for the Year Ended 31 March 2023

24. Share based payments (continued)

2022 Senior management awards (TSR)	Weighted average exercise price 2023 £	2023 No.	Weighted average exercise price 2022 £	2022 No.
At the start of the year	-	-	-	-
Lapsed	£0.00	(24,950)	-	-
Granted	£0.00	112,275	-	-
Exercised	-	-	-	-
At the end of the year	£0.00	87,325	-	-

2022 Senior management awards (EPS)	Weighted average exercise price 2023 £	2023 No.	Weighted average exercise price 2022 £	2022 No.
At the start of the year	-	-	-	-
Lapsed	£0.00	(24,950)	-	-
Granted	£0.00	112,275	-	-
Exercised	-	-	-	-
At the end of the year	£0.00	87,325	-	-

The profit and loss expense that has been recognised in the current year in respect of the Unapproved Scheme is £1,309,000 (2022: £1,295,000).

The vesting of most of these awards is subject to the Group achieving certain performance targets under the Unapproved Scheme, measured over a three or five year period, as set out in the Remuneration Report. The options will vest depending on achievement of the Group's absolute total shareholder return ("TSR") as follows:

The awards under the CSOP Scheme and Unapproved Scheme to employees other than as noted above are not subject to performance conditions and vest subject to continued employment only.

In respect of the CFO and CFO awards, the fair value at grant date is independently determined using a Monte Carlo simulation model which calculates a fair value based on a large number of randomly generated projections of the Company's future share prices. In respect of the CSOP and Unapproved Schemes, the fair value at grant date has been determined using a Black-Scholes model that takes into account the exercise price, the term of the option, the share price at grant date and expected price volatility of the underlying share, and the risk-free interest rate for the term of the option as shown overleaf:

Notes to the Group financial statements continued

for the Year Ended 31 March 2023

24. Share based payments (continued)

	2018 unapproved scheme	2021 CSOP	2021 unapproved scheme	2021 3 year CEO award	2021 5 year CEO award	2021 CFO awards	2021 SAYE scheme	2022 Senior mgmt. awards - TSR	2022 Senior mgmt. awards - EPS
Grant date	4 Jan 2021	16 Feb 2021	16 Feb 2021	9 Mar 2021	9 Mar 2021	9 Mar 2021	18 Mar 2021	5 Aug 2022	5 Aug 2022
Share price at grant date (pence)	134p	176p	176p	185p	185p	185p	190p	101p	101p
Exercise price (pence)	38.38p	174p	174p	£nil	£nil	£nil	154p	£nil	£nil
Expected volatility (%)	45%	45%	45%	45%	45%	45%	55%	55%	55%
Projection period (yrs)	2.65	n/a	n/a	2.89	0.89	2.89	3.16	2.65	n/a
Expected life (yrs)	3	3	3	3	5	3	3	3	3
Expected dividend yield (%)	5.94%	4.10%	4.10%	3.90%	3.90%	3.90%	3.79%	5.94%	5.94%
Risk free interest rate (%)	-0.09%	0.34%	0.34%	0.12%	0.31%	0.12%	0.14%	1.92%	1.92%
Fair value per award (pence)	71p	50p	50p	74p	59p	109p	59p	31p	75p

The expected volatility has been estimated based upon the historical volatility of the FTSE AIM Retailers and Personal & Household goods sub sectors.

No awards are exercisable at the end of the year. The charge for share-based payments in the year was £1,460,000 (2022: £1,663,000) which is included within Adjusted items. Of this, £177,000 related to Employers National Insurance Contributions and £1,283,000 related to the share-based payments charge.

Notes to the Group financial statements continued

for the Year Ended 31 March 2023

25. Business combinations

Acquisition of Cuts Ice Limited

On 8 August 2022 Supreme Imports Limited acquired the trade and assets of Cuts Ice Limited ("Cuts Ice") and Flavour Core Limited ("Flavour Core"), for consideration of £2,571,000. Cuts Ice is an independent vaping manufacturer with major own brands as well as OEM manufacturing contracts, and Flavour Core is a flavour development and regulatory compliance business in e-liquids.

Recognised amounts of identifiable assets acquired and liabilities assumed

	Book value	Fair value adjustment	Fair value
	£'000	£'000	£'000
Fixed assets
Other intangible assets	-	1,389	1,389
Property, plant and equipment	300	-	300
	300	1,389	1,689
Current assets
Inventory	1,188	(339)	849
Debtors due within one year	33	-	33
	1,221	(339)	882
Total assets	1,521	1,050	2,571

Creditors
Deferred tax	-	(40)	(40)
	-	(40)	(40)
Total identifiable net assets	1,521	1,010	2,531
Goodwill			40
Total purchase consideration			2,571

Consideration
Cash			2,571
Total purchase consideration			2,571

Cash outflow on acquisition
Purchase consideration settled in cash, as above			2,571
Less: cash and cash equivalents acquired			-
Net cash outflow on acquisition			2,571

Following a purchase price allocation exercise the company identified further acquired intangible assets. The fair value adjustments reflect the recognition of the Trade name of £1,231,000 and other intangible assets of £158,000. Deferred tax of £40,000 was recognised on the acquired intangible assets.

Goodwill of £40,000 represents consolidated purchasing and operating synergies.

The revenue from Cuts Ice Limited included in the Statement of Comprehensive Income for 2023 was £3,326,000. Cuts Ice Limited also incurred a gross profit of £2,187,000 over the same period. Had the acquisition occurred on 1^st April 2022 , consolidated revenue and gross profit would have increased by a further £1,663,000 and £1,090,000 respectively.

Notes to the Group financial statements continued

for the Year Ended 31 March 2023

25. Business combinations (continued)

Acquisition of Liberty Flights Holdings Limited

On 10 June 2022 Supreme Imports Limited acquired the entire share capital of Liberty Flights Holdings Limited ("Liberty Flights"), a leading UK vaping manufacturer best known for their Liberty Flights vaping brand and the market-leading Dot Pro device, for initial consideration of £9,350,000.

Recognised amounts of identifiable assets acquired and liabilities assumed

	Book value	Fair value adjustment	Fair value
	£'000	£'000	£'000
Fixed assets
Other intangible assets	62	5,181	5,243
Property, plant and equipment	1,251	415	1,666
	1,313	5,596	6,909
Current assets
Inventory	1,715	-	1,715
Debtors due within one year	1,160	-	1,160
Cash at bank and in hand	1,866	-	1,866
	4,741	-	4,741
Total assets	6,054	5,596	11,650

Creditors
Trade and other payables	(894)	-	(894)
Corporation tax	(77)	-	(77)
Deferred tax	(119)	(1,399)	(1,518)
	(1,090)	(1,399)	(2,489)
Total identifiable net assets	4,964	4,197	9,161
Goodwill			4,144
Total purchase consideration			13,305

Consideration
Cash			9,350
Deferred consideration			1,755
Contingent consideration			2,200
Total purchase consideration			13,305

Cash outflow on acquisition
Purchase consideration settled in cash, as above			9,350
Less: cash and cash equivalents acquired			(1,866)
Net cash outflow on acquisition			7,484

Following a purchase price allocation exercise the company identified further acquired intangible assets. The fair value adjustments reflect the recognition of Customer Relationships of £2,028,000 and the Trade name of £3,153,000. The additional consideration paid over the fair value of the net assets acquired is recognised as goodwill. Deferred tax of £1,295,000 was recognised on the acquired intangible assets.

Goodwill of £4,144,000 represents consolidated purchasing synergies, operating efficiencies and cross sell opportunities.

Debtors due within one year of £1,160,000 are shown net of a £111,000 bad debt provision.

Notes to the Group financial statements continued

for the Year Ended 31 March 2023

25. Business combinations (continued)

Deferred consideration of £2m is payable of the first anniversary of the acquisition. This amount has been discounted in the previous table.

Contingent consideration is based on the performance of Liberty Flights in the 12 months immediately following the acquisition, and could range from £0 to £5,000,000.

The Group has adopted the following fair value hierarchy in relation to its forward contracts derivatives that are carried in the balance sheet at the fair values at year end:

· Quoted prices (unadjusted) in active markets for identical assets or liabilities (level 1);

· Inputs other than quoted prices included within level 1 that are observable for the asset or liability, either directly (that is, as prices) or indirectly (that is, derived from prices) (level 2);

· Inputs for the asset or liability that are not based on observable market data (unobservable inputs) (level 3).

The following table sets out the fair value of all financial assets and liabilities that are measured at fair value:

Group and Company	Level 1 £'000	Level 2 £'000	Level 3 £'000
Liabilities measured at fair value	-	-	-
Contingent consideration	-	-	2,200
Total	-	-	2,200

There is no prior year comparison in the table above due to the acquisition only occurring in 2023. Contingent consideration is included in Level 3 of the fair value hierarchy. The provision for contingent consideration is in respect of the Liberty Flights acquisition in June 2022. The fair value is determined considering the expected payments, discounted to present value using a risk adjusted discount rate.

The significant unobservable inputs are the financial performance forecasts for the twelve month period post-acquisition and the risk adjusted discount rate of 14%.

The estimated fair value would increase or decrease if the EBITDA was higher or lower or the risk adjusted
discount rate was higher or lower. A reasonably possible change to one of these significant unobservable inputs, holding the other inputs constant, would have the following effects:

Group and Company

Effect of change in assumption on income statement

Increase

£'000

Decrease

£'000

EBITDA movement of £100,000

100

The revenue from Liberty Flights Holdings Limited included in the Statement of Comprehensive Income for 2023 was £9,437,000. Liberty Flights Holdings Limited also incurred a profit after tax of £1,260,000 over the same period. Had the acquisition occurred on 1^st April 2022, the Group consolidated revenue and profit after tax would have increased by a further £1,900,000 and £250,000 respectively.

Acquisition of Superdragon

On 30 March 2023, Supreme Imports Limited acquired the trade and assets of Superdragon TCM UK Limited, an independent vaping manufacturer, for initial consideration of £2,470,000, with a further £187,000 deferred.

Recognised amounts of identifiable assets acquired and liabilities assumed

	Book value	Fair value adjustment	Fair value
	£'000	£'000	£'000
Fixed assets
Goodwill and other intangible assets	-	1,162	1,162
	-	1,162	1,162
Current assets
Inventory	260	(196)	64
	260	(196)	64
Total assets	260	966	1,226

Creditors
Deferred tax	-	(291)	(291)
	-	(291)	(291)
Total identifiable net assets	260	675	935
Goodwill			1,722
Total purchase consideration			2,657

Consideration
Cash			2,470
Deferred consideration			187
Total purchase consideration			2,657

The above cash consideration of £2,470,000 was settled in April 2023 and as such no cash outflow arose on acquisition for the year ended 31 March 2023.

Following a purchase price allocation exercise the company identified further acquired intangible assets. The fair value adjustments reflect the recognition of Customer Relationships of £978,000 and other intangible assets of £184,000. The additional consideration paid over the fair value of the net assets acquired is recognised as goodwill. Deferred tax of £291,000 was recognised on the acquired intangible assets.

Goodwill of £1,722,000 represents consolidated purchasing and operating synergies.

The revenue from Superdragon included in the Statement of Comprehensive Income for 2023 was £Nil, as was the profit. The assets were acquired on the last day of the financial year.

Notes to the Group financial statements continued

for the Year Ended 31 March 2023

26. Ultimate controlling party

The Directors consider the ultimate controlling party to be S Chadha and his concert party.

27. Other financial commitments

See note 22.5 for details of the financial commitments under US dollar forward exchange contracts.

28. Related party transactions

28.1. Remuneration of key personnel

Remuneration of key management personnel, considered to be the Directors of the Company and members of the senior management team is as follows:

	Year Ended 31 March 2023	Year Ended 31 March 2022
	£'000	£'000

Short-term employee benefits	1,152	1,030
Social security costs	159	126
Employee share schemes	1,405	1,402
Post-employment benefits	8	9
Total compensation	2,724	2,567

28.2. Transactions and balances with key personnel

	As at 31 March 2023	As at 31 March 2022
	£'000	£'000
Loan balances with Directors:
Balance outstanding from director	(2)	(2)

28.3. Transactions and balances with related companies and businesses

	Year Ended / As at 31 March 2023	Year Ended / As at 31 March 2022
	£'000	£'000
Transactions with related companies:
Rent paid to Chadha Properties Limited	180	180

Balances with related companies:
Amounts owed by Nash Peters Limited	-	-
Amounts owed to Supreme 8 Limited	-	(1,780)

The above companies are related due to common control and Directors.

On 30 March 2023 the landlord of Beacon Road, Supreme's principal operating site, changed from Chadha Properties Limited to Supreme 8 Limited, both of which are related parties. On 5 May 2023 a new lease was signed between Supreme 8 Limited and Supreme Imports Limited for a term of 5 years from 16 March 2023. Rent to be paid to Supreme 8 Limited in respect of Beacon Road will be £374,000 per annum (plus VAT) and will continue to be disclosed as a transaction with related parties.

Notes to the Group financial statements continued

for the Year Ended 31 March 2023

29. Net cash flows in financing activities

	Net debt as at 1 April 2021	Payments		New leases		Arising on acquisition		Foreign exchange adjustments		Interest expense		Interest payments		Non current to current movement		Net debt as at 31 March 2022

Long term loan - current	(6,469)	5,305	-		-		-		(575)		285		(2,530)		(3,984)
Long term loan - non current	(3,695)	1,165	-		-		-		-		-		2,530		-
Leases - current	(615)	837	(270)		-		-		(46)		46		(854)		(902)
Leases - non current	(963)	-	(1,185)		-		-		(72)		72		854		(1,294)
Amount owed to related parties - current	(1,613)	1,613	-		-		-		-		-		(1,779)		(1,779)
Amount owed to related parties - non current	(1,779)	-	-		-		-		-		-		1,779		-
Sub-total	(15,134)	8,920	(1,455)		-		-		(693)		403		-		(7,959)
Cash at bank and in hand	7,505	(3,818)				271		(32)		-		-		-		3,926
Total	(7,629)	5,102		(1,455)		271		(32)		(693)		403		-		(4,033)

	Net debt as at 1 April 2022	Payments	Drawdowns	New leases	Arising on acquisition	Foreign exchange adjustments	Interest expense	Interest payments	Movement on loan costs	Non current to current movement	Net debt as at 31 March 2023
Long term loan - current	(3,984)	3,984		-	-	-	-	-	-	-	-
Long term loan - non current	-	-		-	-	-	-	-	-	-	-
RCF - non current	-	14,000	(18,418)	-	-	-	(883)	776	218	-	(4,307)
Leases - current	(902)	834		(647)	-	-	(7)	7	-	(4)	(719)
Leases - non current	(1,294)	-		(13,003)	-	-	(146)	146	-	4	(14,293)
Amount owed to related parties - current	(1,779)	1,779		-	-	-	-	-	-	-	-
Sub-total	(7,959)	20,597	(18,418)	(13,650)	-	-	(1,036)	929	218	-	(19,319)
Cash at bank and in hand	3,926	1,643		-	1,866	101	-	-	-	-	7,536
Total	(4,033)	22,240	(18,418)	(13,650)	1,866	101	(1,036)	929	218	-	(11,783)

Notes to the Group financial statements continued

for the Year Ended 31 March 2023

30. Post balance date events

There have been no post balance date events to note.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

Companies

Supreme (SUP)

Friday, 26th April 2024

COMPANIES COVERED:

AAL CAR NWG

Anglo American rebuts bid approach from BHP, Nat West Group interim management statement gives shareholders something to cheer and Carclo’s better than expected results see share price surge despite debt burden.

Full Archive

UK 100

Latest directors dealings

2 days ago Next
2 days ago CT Private Equity Trust
2 days ago Kingfisher
2 days ago Kingfisher
2 days ago Rio Tinto

All directors dealings today